{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:44:49Z","timestamp":1792107889451,"version":"4.4.0"},"reference-count":301,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":287,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-06192-1","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:53:04Z","timestamp":1792104784000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gut Microbiota Modulation in CNS Disorders: Therapeutic Strategies and Implications for Drug Efficacy"],"prefix":"10.1007","volume":"63","author":[{"given":"Lamiaa A.","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled F.","family":"Al-Massri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,15]]},"reference":[{"key":"6192_CR1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13024-022-00524-0","volume":"17","author":"LK Wareham","year":"2022","unstructured":"Wareham LK, Liddelow SA, Temple S, Benowitz LI, Di Polo A, Wellington C et al (2022) Solving neurodegeneration: common mechanisms and strategies for new treatments. Mol Neurodegener 17:23. https:\/\/doi.org\/10.1186\/s13024-022-00524-0","journal-title":"Mol Neurodegener"},{"key":"6192_CR2","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.jare.2024.03.023","volume":"69","author":"W Tao","year":"2025","unstructured":"Tao W, Zhang Y, Wang B, Nie S, Fang L, Xiao J et al (2025) Advances in molecular mechanisms and therapeutic strategies for central nervous system diseases based on gut microbiota imbalance. J Adv Res 69:261\u2013278. https:\/\/doi.org\/10.1016\/j.jare.2024.03.023","journal-title":"J Adv Res"},{"key":"6192_CR3","doi-asserted-by":"publisher","first-page":"1091165","DOI":"10.3389\/fimmu.2023.1091165","volume":"14","author":"Y Sun","year":"2023","unstructured":"Sun Y, Wen M, Liu Y, Wang Y, Jing P, Gu Z et al (2023) The human microbiome: a promising target for lung cancer treatment. Front Immunol 14:1091165. https:\/\/doi.org\/10.3389\/fimmu.2023.1091165","journal-title":"Front Immunol"},{"key":"6192_CR4","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1126\/science.1110591","volume":"308","author":"PB Eckburg","year":"2005","unstructured":"Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M et al (2005) Diversity of the human intestinal microbial flora. Science 308:1635\u20131638. https:\/\/doi.org\/10.1126\/science.1110591","journal-title":"Science"},{"key":"6192_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/nu15143258","volume":"15","author":"RG Xiong","year":"2023","unstructured":"Xiong RG, Li J, Cheng J, Zhou DD, Wu SX, Huang SY et al (2023) The role of gut microbiota in anxiety, depression, and other mental disorders as well as the protective effects of dietary components. Nutrients 15:3258. https:\/\/doi.org\/10.3390\/nu15143258","journal-title":"Nutrients"},{"key":"6192_CR6","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.eplepsyres.2018.09.013","volume":"147","author":"A Peng","year":"2018","unstructured":"Peng A, Qiu X, Lai W, Li W, Zhang L, Zhu X et al (2018) Altered composition of the gut microbiome in patients with drug-resistant epilepsy. Epilepsy Res 147:102\u2013107. https:\/\/doi.org\/10.1016\/j.eplepsyres.2018.09.013","journal-title":"Epilepsy Res"},{"key":"6192_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232213665","volume":"23","author":"B Bonnech\u00e8re","year":"2022","unstructured":"Bonnech\u00e8re B, Amin N, van Duijn C (2022) What are the key gut microbiota involved in neurological diseases? A systematic review. Int J Mol Sci 23:13665. https:\/\/doi.org\/10.3390\/ijms232213665","journal-title":"Int J Mol Sci"},{"key":"6192_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2024.e00478","volume":"21","author":"A Keshavarzian","year":"2024","unstructured":"Keshavarzian A, Sisodia SS (2024) Gut microbiota dysbiosis and neurologic diseases: new horizon with potential diagnostic and therapeutic impact. Neurotherapeutics 21:e00478. https:\/\/doi.org\/10.1016\/j.neurot.2024.e00478","journal-title":"Neurotherapeutics"},{"key":"6192_CR9","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrn3071","volume":"12","author":"EA Mayer","year":"2011","unstructured":"Mayer EA (2011) Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci 12:453\u2013466. https:\/\/doi.org\/10.1038\/nrn3071","journal-title":"Nat Rev Neurosci"},{"key":"6192_CR10","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00401-018-1856-5","volume":"136","author":"C Pellegrini","year":"2018","unstructured":"Pellegrini C, Antonioli L, Colucci R, Blandizzi C, Fornai M (2018) Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: a common path to neurodegenerative diseases? Acta Neuropathol 136:345\u201361. https:\/\/doi.org\/10.1007\/s00401-018-1856-5","journal-title":"Acta Neuropathol"},{"key":"6192_CR11","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.1080\/10408398.2018.1484340","volume":"59","author":"A Larroya-Garcia","year":"2019","unstructured":"Larroya-Garcia A, Navas-Carrillo D, Orenes-Pinero E (2019) Impact of gut microbiota on neurological diseases: diet composition and novel treatments. Crit Rev Food Sci Nutr 59:3102\u201316. https:\/\/doi.org\/10.1080\/10408398.2018.1484340","journal-title":"Crit Rev Food Sci Nutr"},{"key":"6192_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1274925","volume":"14","author":"G Huang","year":"2023","unstructured":"Huang G, Khan R, Zheng Y, Lee PC, Li Q, Khan I (2023) Exploring the role of gut microbiota in advancing personalized medicine. Front Microbiol 14:1274925. https:\/\/doi.org\/10.3389\/fmicb.2023.1274925","journal-title":"Front Microbiol"},{"key":"6192_CR13","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00058-23","volume":"11","author":"L Qian","year":"2023","unstructured":"Qian L, He X, Liu Y, Gao F, Lu W, Fan Y et al (2023) Longitudinal gut microbiota dysbiosis underlies olanzapine-induced weight gain. Microbiol Spectr 11:e0005823. https:\/\/doi.org\/10.1128\/spectrum.00058-23","journal-title":"Microbiol Spectr"},{"key":"6192_CR14","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nrgastro.2017.20","volume":"14","author":"JL Alexander","year":"2017","unstructured":"Alexander JL, Wilson ID, Teare J, Marchesi JR, Nicholson JK, Kinross JM (2017) Gut microbiota modulation of chemotherapy efficacy and toxicity. Nat Rev Gastroenterol Hepatol 14:356\u2013365. https:\/\/doi.org\/10.1038\/nrgastro.2017.20","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"6192_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.742449","volume":"12","author":"M Ding","year":"2021","unstructured":"Ding M, Lang Y, Shu H, Shao J, Cui L (2021) Microbiota-gut-brain axis and epilepsy: a review on mechanisms and potential therapeutics. Front Immunol 12:742449. https:\/\/doi.org\/10.3389\/fimmu.2021.742449","journal-title":"Front Immunol"},{"key":"6192_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10061299","author":"J Ojeda","year":"2021","unstructured":"Ojeda J, \u00c1vila A, Vidal PM (2021) Gut microbiota interaction with the central nervous system throughout life. J Clin Med. https:\/\/doi.org\/10.3390\/jcm10061299","journal-title":"J Clin Med"},{"key":"6192_CR17","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3233\/NHA-170030","volume":"4","author":"R Nagpal","year":"2018","unstructured":"Nagpal R, Mainali R, Ahmadi S, Wang S, Singh R, Kavanagh K et al (2018) Gut microbiome and aging: physiological and mechanistic insights. Nutr Healthy Aging 4:267\u2013285. https:\/\/doi.org\/10.3233\/NHA-170030","journal-title":"Nutr Healthy Aging"},{"key":"6192_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2020.110051","volume":"104","author":"M Naveed","year":"2021","unstructured":"Naveed M, Zhou QG, Xu C, Taleb A, Meng F, Ahmed B et al (2021) Gut-brain axis: a matter of concern in neuropsychiatric disorders...! Prog Neuropsychopharmacol Biol Psychiatry 104:110051. https:\/\/doi.org\/10.1016\/j.pnpbp.2020.110051","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"6192_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.12904","volume":"29","author":"K Pokusaeva","year":"2017","unstructured":"Pokusaeva K, Johnson C, Luk B, Uribe G, Fu Y, Oezguen N et al (2017) GABA-producing Bifidobacterium dentium modulates visceral sensitivity in the intestine. Neurogastroenterol Motil 29:e12904. https:\/\/doi.org\/10.1111\/nmo.12904","journal-title":"Neurogastroenterol Motil"},{"key":"6192_CR20","doi-asserted-by":"publisher","first-page":"795","DOI":"10.3136\/fstr.18.795","volume":"18","author":"F \u00d6Zo\u011eUl","year":"2012","unstructured":"\u00d6Zo\u011eUl F, Kuley E, \u00d6Zo\u011eUl Y, \u00d6Zo\u011eUl \u0130 (2012) The function of lactic acid bacteria on biogenic amines production by food-borne pathogens in arginine decarboxylase broth. Food Sci Technol Res 18:795\u2013804. https:\/\/doi.org\/10.3136\/fstr.18.795","journal-title":"Food Sci Technol Res"},{"key":"6192_CR21","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1134\/s0003683809050068","volume":"45","author":"VA Shishov","year":"2009","unstructured":"Shishov VA, Kirovskaya TA, Kudrin VS, Oleskin AV (2009) Amine neuromediators, their precursors, and oxidation products in the culture of Escherichia coli K-12. Appl Biochem Microbiol 45:494\u2013497. https:\/\/doi.org\/10.1134\/s0003683809050068","journal-title":"Appl Biochem Microbiol"},{"key":"6192_CR22","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1016\/j.lfs.2007.01.059","volume":"80","author":"K Kawashima","year":"2007","unstructured":"Kawashima K, Misawa H, Moriwaki Y, Fujii YX, Fujii T, Horiuchi Y et al (2007) Ubiquitous expression of acetylcholine and its biological functions in life forms without nervous systems. Life Sci 80:2206\u20132209. https:\/\/doi.org\/10.1016\/j.lfs.2007.01.059","journal-title":"Life Sci"},{"key":"6192_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13112810","author":"G D\u2019Alessandro","year":"2021","unstructured":"D\u2019Alessandro G, Lauro C, Quaglio D, Ghirga F, Botta B, Trettel F et al (2021) Neuro-signals from gut microbiota: perspectives for brain glioma. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13112810","journal-title":"Cancers (Basel)"},{"key":"6192_CR24","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.3390\/nu13062099","volume":"13","author":"Y Chen","year":"2021","unstructured":"Chen Y, Xu J, Chen Y (2021) Regulation of neurotransmitters by the gut microbiota and effects on cognition in neurological disorders. Nutrients 13:2099. https:\/\/doi.org\/10.3390\/nu13062099","journal-title":"Nutrients"},{"key":"6192_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2021.105640","volume":"137","author":"C Barrio","year":"2022","unstructured":"Barrio C, Arias-S\u00e1nchez S, Mart\u00edn-Monz\u00f3n I (2022) The gut microbiota-brain axis, psychobiotics and its influence on brain and behaviour: a systematic review. Psychoneuroendocrinology 137:105640. https:\/\/doi.org\/10.1016\/j.psyneuen.2021.105640","journal-title":"Psychoneuroendocrinology"},{"key":"6192_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-026-03824-0","volume":"23","author":"M Santerre","year":"2026","unstructured":"Santerre M, Shcherbik N, Sawaya BE (2026) Microbiota as a regulator of brain vulnerability across lifespan and disease contexts. J Neuroinflammation 23:186. https:\/\/doi.org\/10.1186\/s12974-026-03824-0","journal-title":"J Neuroinflammation"},{"key":"6192_CR27","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1136\/gutjnl-2014-306931","volume":"64","author":"M Olivares","year":"2015","unstructured":"Olivares M, Neef A, Castillejo G, Palma GD, Varea V, Capilla A et al (2015) The HLA-DQ2 genotype selects for early intestinal microbiota composition in infants at high risk of developing coeliac disease. Gut 64:406\u2013417. https:\/\/doi.org\/10.1136\/gutjnl-2014-306931","journal-title":"Gut"},{"key":"6192_CR28","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/gbb.12109","volume":"13","author":"RM Stilling","year":"2014","unstructured":"Stilling RM, Dinan TG, Cryan JF (2014) Microbial genes, brain & behaviour - epigenetic regulation of the gut-brain axis. Genes Brain Behav 13:69\u201386. https:\/\/doi.org\/10.1111\/gbb.12109","journal-title":"Genes Brain Behav"},{"key":"6192_CR29","doi-asserted-by":"publisher","DOI":"10.1172\/JCI143775","author":"A Singh","year":"2021","unstructured":"Singh A, Dawson TM, Kulkarni S (2021) Neurodegenerative disorders and gut-brain interactions. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI143775","journal-title":"J Clin Invest"},{"key":"6192_CR30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2174\/1874467215666220222105004","volume":"16","author":"LA Ahmed","year":"2023","unstructured":"Ahmed LA, Al-Massri KF (2023) Gut microbiota modulation for therapeutic management of various diseases: a new perspective using stem cell therapy. Curr Mol Pharmacol 16:43\u201359. https:\/\/doi.org\/10.2174\/1874467215666220222105004","journal-title":"Curr Mol Pharmacol"},{"key":"6192_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.718356","volume":"8","author":"G Barbara","year":"2021","unstructured":"Barbara G, Barbaro MR, Fuschi D, Palombo M, Falangone F, Cremon C et al (2021) Inflammatory and microbiota-related regulation of the intestinal epithelial barrier. Front Nutr 8:718356. https:\/\/doi.org\/10.3389\/fnut.2021.718356","journal-title":"Front Nutr"},{"key":"6192_CR32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/17843286.2019.1583782","volume":"74","author":"G Falony","year":"2019","unstructured":"Falony G, Vandeputte D, Caenepeel C, Vieira-Silva S, Daryoush T, Vermeire S et al (2019) The human microbiome in health and disease: hype or hope. Acta Clin Belg 74:53\u201364. https:\/\/doi.org\/10.1080\/17843286.2019.1583782","journal-title":"Acta Clin Belg"},{"key":"6192_CR33","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1212\/WNL.0000000000003391","volume":"87","author":"X Zhan","year":"2016","unstructured":"Zhan X, Stamova B, Jin LW, DeCarli C, Phinney B, Sharp FR (2016) Gram-negative bacterial molecules associate with Alzheimer disease pathology. Neurology 87:2324\u20132332. https:\/\/doi.org\/10.1212\/WNL.0000000000003391","journal-title":"Neurology"},{"key":"6192_CR34","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3389\/fnmol.2015.00077","volume":"8","author":"RH Shih","year":"2015","unstructured":"Shih RH, Wang CY, Yang CM (2015) NF-kappaB signaling pathways in neurological inflammation: a mini review. Front Mol Neurosci 8:77. https:\/\/doi.org\/10.3389\/fnmol.2015.00077","journal-title":"Front Mol Neurosci"},{"key":"6192_CR35","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.bbi.2009.01.017","volume":"23","author":"LB Jaeger","year":"2009","unstructured":"Jaeger LB, Dohgu S, Sultana R, Lynch JL, Owen JB, Erickson MA et al (2009) Lipopolysaccharide alters the blood-brain barrier transport of amyloid beta protein: a mechanism for inflammation in the progression of Alzheimer\u2019s disease. Brain Behav Immun 23:507\u2013517. https:\/\/doi.org\/10.1016\/j.bbi.2009.01.017","journal-title":"Brain Behav Immun"},{"key":"6192_CR36","doi-asserted-by":"publisher","first-page":"2167172","DOI":"10.1080\/19490976.2023.2167172","volume":"15","author":"J Jin","year":"2023","unstructured":"Jin J, Xu Z, Zhang L, Zhang C, Zhao X, Mao Y et al (2023) Gut-derived beta-amyloid: likely a centerpiece of the gut-brain axis contributing to Alzheimer\u2019s pathogenesis. Gut Microbes 15:2167172. https:\/\/doi.org\/10.1080\/19490976.2023.2167172","journal-title":"Gut Microbes"},{"key":"6192_CR37","doi-asserted-by":"publisher","unstructured":"Traini C, Bulli I, Sarti G, Morecchiato F, Coppi M, Rossolini GM et al (2024) Amelioration of serum abeta levels and cognitive impairment in APPPS1 transgenic mice following symbiotic administration. Nutrients 16. https:\/\/doi.org\/10.3390\/nu16152381","DOI":"10.3390\/nu16152381"},{"key":"6192_CR38","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s13195-024-01597-3","volume":"16","author":"M Pils","year":"2024","unstructured":"Pils M, Dybala A, Schaffrath A, Rehn F, Kutzsche J, Blomeke L et al (2024) Elevated Abeta aggregates in feces from Alzheimer\u2019s disease patients: a proof-of-concept study. Alzheimers Res Ther 16:223. https:\/\/doi.org\/10.1186\/s13195-024-01597-3","journal-title":"Alzheimers Res Ther"},{"key":"6192_CR39","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3390\/biology102020195","volume":"12","author":"G Intili","year":"2023","unstructured":"Intili G, Paladino L, Rappa F, Alberti G, Plicato A, Calabr\u00f2 F et al (2023) From dysbiosis to neurodegenerative diseases through different communication pathways: an overview. Biology 12:195. https:\/\/doi.org\/10.3390\/biology102020195","journal-title":"Biology"},{"key":"6192_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212856","volume":"14","author":"M Bistoletti","year":"2019","unstructured":"Bistoletti M, Caputi V, Baranzini N, Marchesi N, Filpa V, Marsilio I et al (2019) Antibiotic treatment-induced dysbiosis differently affects BDNF and TrkB expression in the brain and in the gut of juvenile mice. PLoS ONE 14:e0212856. https:\/\/doi.org\/10.1371\/journal.pone.0212856","journal-title":"PLoS ONE"},{"key":"6192_CR41","doi-asserted-by":"publisher","first-page":"13537","DOI":"10.1038\/s41598-017-13601-y","volume":"7","author":"NM Vogt","year":"2017","unstructured":"Vogt NM, Kerby RL, Dill-McFarland KA, Harding SJ, Merluzzi AP, Johnson SC et al (2017) Gut microbiome alterations in Alzheimer\u2019s disease. Sci Rep 7:13537. https:\/\/doi.org\/10.1038\/s41598-017-13601-y","journal-title":"Sci Rep"},{"key":"6192_CR42","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.bbi.2019.05.008","volume":"80","author":"P Liu","year":"2019","unstructured":"Liu P, Wu L, Peng G, Han Y, Tang R, Ge J et al (2019) Altered microbiomes distinguish Alzheimer\u2019s disease from amnestic mild cognitive impairment and health in a Chinese cohort. Brain Behav Immun 80:633\u2013643. https:\/\/doi.org\/10.1016\/j.bbi.2019.05.008","journal-title":"Brain Behav Immun"},{"key":"6192_CR43","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.3233\/jad-180176","volume":"63","author":"ZQ Zhuang","year":"2018","unstructured":"Zhuang ZQ, Shen LL, Li WW, Fu X, Zeng F, Gui L et al (2018) Gut microbiota is altered in patients with Alzheimer\u2019s disease. J Alzheimers Dis 63:1337\u20131346. https:\/\/doi.org\/10.3233\/jad-180176","journal-title":"J Alzheimers Dis"},{"key":"6192_CR44","doi-asserted-by":"publisher","first-page":"5771","DOI":"10.1002\/alz.14057","volume":"20","author":"Y Liang","year":"2024","unstructured":"Liang Y, Liu C, Cheng M, Geng L, Li J, Du W et al (2024) The link between gut microbiome and Alzheimer\u2019s disease: from the perspective of new revised criteria for diagnosis and staging of Alzheimer\u2019s disease. Alzheimers Dement 20:5771\u20135788. https:\/\/doi.org\/10.1002\/alz.14057","journal-title":"Alzheimers Dement"},{"key":"6192_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-021-00156-z","volume":"7","author":"S Romano","year":"2021","unstructured":"Romano S, Savva GM, Bedarf JR, Charles IG, Hildebrand F, Narbad A (2021) Meta-analysis of the Parkinson\u2019s disease gut microbiome suggests alterations linked to intestinal inflammation. NPJ Parkinsons Dis 7:27. https:\/\/doi.org\/10.1038\/s41531-021-00156-z","journal-title":"NPJ Parkinsons Dis"},{"key":"6192_CR46","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1002\/mds.28119","volume":"35","author":"H Nishiwaki","year":"2020","unstructured":"Nishiwaki H, Ito M, Ishida T, Hamaguchi T, Maeda T, Kashihara K et al (2020) Meta-analysis of gut dysbiosis in Parkinson\u2019s disease. Mov Disord 35:1626\u20131635. https:\/\/doi.org\/10.1002\/mds.28119","journal-title":"Mov Disord"},{"key":"6192_CR47","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.neubiorev.2020.02.003","volume":"112","author":"ND Nuzum","year":"2020","unstructured":"Nuzum ND, Loughman A, Szymlek-Gay EA, Hendy A, Teo WP, Macpherson H (2020) Gut microbiota differences between healthy older adults and individuals with Parkinson\u2019s disease: a systematic review. Neurosci Biobehav Rev 112:227\u2013241. https:\/\/doi.org\/10.1016\/j.neubiorev.2020.02.003","journal-title":"Neurosci Biobehav Rev"},{"key":"6192_CR48","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.ebiom.2019.05.064","volume":"44","author":"VTE Aho","year":"2019","unstructured":"Aho VTE, Pereira PAB, Voutilainen S, Paulin L, Pekkonen E, Auvinen P et al (2019) Gut microbiota in Parkinson\u2019s disease: temporal stability and relations to disease progression. EBioMedicine 44:691\u2013707. https:\/\/doi.org\/10.1016\/j.ebiom.2019.05.064","journal-title":"EBioMedicine"},{"key":"6192_CR49","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s12017-019-08539-5","volume":"21","author":"Y Kishimoto","year":"2019","unstructured":"Kishimoto Y, Zhu W, Hosoda W, Sen JM, Mattson MP (2019) Chronic mild gut inflammation accelerates brain neuropathology and motor dysfunction in alpha-synuclein mutant mice. Neuromolecular Med 21:239\u2013249. https:\/\/doi.org\/10.1007\/s12017-019-08539-5","journal-title":"Neuromolecular Med"},{"key":"6192_CR50","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00401-010-0664-3","volume":"119","author":"TG Beach","year":"2010","unstructured":"Beach TG, Adler CH, Sue LI, Vedders L, Lue L, White Iii CL et al (2010) Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol 119:689\u2013702. https:\/\/doi.org\/10.1007\/s00401-010-0664-3","journal-title":"Acta Neuropathol"},{"key":"6192_CR51","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00401-013-1214-6","volume":"127","author":"D Hilton","year":"2014","unstructured":"Hilton D, Stephens M, Kirk L, Edwards P, Potter R, Zajicek J et al (2014) Accumulation of alpha-synuclein in the bowel of patients in the pre-clinical phase of Parkinson\u2019s disease. Acta Neuropathol 127:235\u2013241. https:\/\/doi.org\/10.1007\/s00401-013-1214-6","journal-title":"Acta Neuropathol"},{"key":"6192_CR52","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3390\/clinpract15060107","volume":"15","author":"JP Rissardo","year":"2025","unstructured":"Rissardo JP, Fornari Caprara AL (2025) Alpha-synuclein seed amplification assays in Parkinson\u2019s disease: a systematic review and network meta-analysis. Clin Pract 15:107. https:\/\/doi.org\/10.3390\/clinpract15060107","journal-title":"Clin Pract"},{"key":"6192_CR53","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/ana.24648","volume":"79","author":"MG Stokholm","year":"2016","unstructured":"Stokholm MG, Danielsen EH, Hamilton-Dutoit SJ, Borghammer P (2016) Pathological alpha-synuclein in gastrointestinal tissues from prodromal Parkinson disease patients. Ann Neurol 79:940\u2013949. https:\/\/doi.org\/10.1002\/ana.24648","journal-title":"Ann Neurol"},{"key":"6192_CR54","doi-asserted-by":"publisher","unstructured":"Lebouvier T, Neunlist M, Bruley des Varannes S, Coron E, Drouard A, N\u2019Guyen JM, et al. (2010) Colonic biopsies to assess the neuropathology of Parkinson\u2019s disease and its relationship with symptoms. PLoS One 5:e12728. https:\/\/doi.org\/10.1371\/journal.pone.0012728","DOI":"10.1371\/journal.pone.0012728"},{"key":"6192_CR55","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41593-020-0589-7","volume":"23","author":"C Challis","year":"2020","unstructured":"Challis C, Hori A, Sampson TR, Yoo BB, Challis RC, Hamilton AM et al (2020) Gut-seeded alpha-synuclein fibrils promote gut dysfunction and brain pathology specifically in aged mice. Nat Neurosci 23:327\u2013336. https:\/\/doi.org\/10.1038\/s41593-020-0589-7","journal-title":"Nat Neurosci"},{"key":"6192_CR56","doi-asserted-by":"publisher","first-page":"1745455","DOI":"10.3389\/fnagi.2026.1745455","volume":"18","author":"TJW Tng","year":"2026","unstructured":"Tng TJW, Vanan S, Tan EK, Zeng L, Goh WWB, Wong SH et al (2026) Examination of shared gut microbiome signatures in aging and Parkinson\u2019s disease. Front Aging Neurosci 18:1745455. https:\/\/doi.org\/10.3389\/fnagi.2026.1745455","journal-title":"Front Aging Neurosci"},{"key":"6192_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2023.109566","volume":"235","author":"ND Nuzum","year":"2023","unstructured":"Nuzum ND, Szymlek-Gay EA, Loke S, Dawson SL, Teo WP, Hendy AM et al (2023) Differences in the gut microbiome across typical ageing and in Parkinson\u2019s disease. Neuropharmacology 235:109566. https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109566","journal-title":"Neuropharmacology"},{"key":"6192_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-69845-8","volume":"10","author":"Q Zeng","year":"2020","unstructured":"Zeng Q, Shen J, Chen K, Zhou J, Liao Q, Lu K et al (2020) The alteration of gut microbiome and metabolism in amyotrophic lateral sclerosis patients. Sci Rep 10:12998. https:\/\/doi.org\/10.1038\/s41598-020-69845-8","journal-title":"Sci Rep"},{"key":"6192_CR59","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41586-020-2288-7","volume":"582","author":"A Burberry","year":"2020","unstructured":"Burberry A, Wells MF, Limone F, Couto A, Smith KS, Keaney J et al (2020) C9orf72 suppresses systemic and neural inflammation induced by gut bacteria. Nature 582:89\u201394. https:\/\/doi.org\/10.1038\/s41586-020-2288-7","journal-title":"Nature"},{"key":"6192_CR60","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s10571-018-0589-2","volume":"38","author":"GB Stefano","year":"2018","unstructured":"Stefano GB, Pilonis N, Ptacek R, Raboch J, Vnukova M, Kream RM (2018) Gut, microbiome, and brain regulatory axis: relevance to neurodegenerative and psychiatric disorders. Cell Mol Neurobiol 38:1197\u20131206. https:\/\/doi.org\/10.1007\/s10571-018-0589-2","journal-title":"Cell Mol Neurobiol"},{"key":"6192_CR61","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jad.2022.01.103","volume":"302","author":"X Li","year":"2022","unstructured":"Li X, Mu F, Liu D, Zhu J, Yue S, Liu M et al (2022) Predictors of suicidal ideation, suicide attempt and suicide death among people with major depressive disorder: a systematic review and meta-analysis of cohort studies. J Affect Disord 302:332\u2013351. https:\/\/doi.org\/10.1016\/j.jad.2022.01.103","journal-title":"J Affect Disord"},{"key":"6192_CR62","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1515\/revneuro-2017-0072","volume":"29","author":"G Winter","year":"2018","unstructured":"Winter G, Hart RA, Charlesworth RPG, Sharpley CF (2018) Gut microbiome and depression: what we know and what we need to know. Rev Neurosci 29:629\u201343. https:\/\/doi.org\/10.1515\/revneuro-2017-0072","journal-title":"Rev Neurosci"},{"key":"6192_CR63","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/WNR.0000000000000985","volume":"29","author":"Z Chen","year":"2018","unstructured":"Chen Z, Li J, Gui S, Zhou C, Chen J, Yang C et al (2018) Comparative metaproteomics analysis shows altered fecal microbiota signatures in patients with major depressive disorder. NeuroReport 29:417\u2013425. https:\/\/doi.org\/10.1097\/WNR.0000000000000985","journal-title":"NeuroReport"},{"key":"6192_CR64","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jad.2016.09.051","volume":"207","author":"P Lin","year":"2017","unstructured":"Lin P, Ding B, Feng C, Yin S, Zhang T, Qi X et al (2017) Prevotella and Klebsiella proportions in fecal microbial communities are potential characteristic parameters for patients with major depressive disorder. J Affect Disord 207:300\u2013304. https:\/\/doi.org\/10.1016\/j.jad.2016.09.051","journal-title":"J Affect Disord"},{"issue":"685\u201394","key":"6192_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2023.02.017","volume":"35","author":"D Li","year":"2023","unstructured":"Li D, Sun T, Tong Y, Le J, Yao Q, Tao J et al (2023) Gut-microbiome-expressed 3beta-hydroxysteroid dehydrogenase degrades estradiol and is linked to depression in premenopausal females. Cell Metab 35(685\u201394):e5. https:\/\/doi.org\/10.1016\/j.cmet.2023.02.017","journal-title":"Cell Metab"},{"key":"6192_CR66","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s40168-022-01428-3","volume":"11","author":"EM Medina-Rodriguez","year":"2023","unstructured":"Medina-Rodriguez EM, Watson J, Reyes J, Trivedi M, Beurel E (2023) Th17 cells sense microbiome to promote depressive-like behaviors. Microbiome 11:92. https:\/\/doi.org\/10.1186\/s40168-022-01428-3","journal-title":"Microbiome"},{"key":"6192_CR67","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.00218-22","volume":"7","author":"B Hu","year":"2022","unstructured":"Hu B, Das P, Lv X, Shi M, Aa J, Wang K et al (2022) Effects of \u2018healthy\u2019 fecal microbiota transplantation against the deterioration of depression in fawn-hooded rats. mSystems 7:e0021822. https:\/\/doi.org\/10.1128\/msystems.00218-22","journal-title":"mSystems"},{"key":"6192_CR68","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.3390\/nu16071039","volume":"16","author":"K Sochacka","year":"2024","unstructured":"Sochacka K, Kotowska A, Lachowicz-Wisniewska S (2024) The role of gut microbiota, nutrition, and physical activity in depression and obesity-interdependent mechanisms\/co-occurrence. Nutrients 16:1039. https:\/\/doi.org\/10.3390\/nu16071039","journal-title":"Nutrients"},{"key":"6192_CR69","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s41398-025-03521-1","volume":"15","author":"SK Lin","year":"2025","unstructured":"Lin SK, Chen HC, Chen IM, Hsu CD, Huang MC, Liu CM et al (2025) Dysbiosis and depression: a study of gut microbiota alterations and functional pathways in antidepressant-naive mood disorder patients. Transl Psychiatry 15:290. https:\/\/doi.org\/10.1038\/s41398-025-03521-1","journal-title":"Transl Psychiatry"},{"key":"6192_CR70","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000533","author":"G Borgiani","year":"2024","unstructured":"Borgiani G, Possidente C, Fabbri C, Oliva V, Bloemendaal M, Vasquez AA et al (2024) The bidirectional interaction between antidepressants and the gut microbiota: are there implications for treatment response? Int Clin Psychopharmacol. https:\/\/doi.org\/10.1097\/YIC.0000000000000533","journal-title":"Int Clin Psychopharmacol"},{"key":"6192_CR71","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3390\/jpm14040391","volume":"14","author":"FEC Mosquera","year":"2024","unstructured":"Mosquera FEC, Guevara-Montoya MC, Serna-Ramirez V, Liscano Y (2024) Neuroinflammation and schizophrenia: new therapeutic strategies through psychobiotics, nanotechnology, and artificial intelligence (AI). J Pers Med 14:391. https:\/\/doi.org\/10.3390\/jpm14040391","journal-title":"J Pers Med"},{"key":"6192_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9080875","author":"M Manchia","year":"2021","unstructured":"Manchia M, Fontana A, Panebianco C, Paribello P, Arzedi C, Cossu E et al (2021) Involvement of gut microbiota in schizophrenia and treatment resistance to antipsychotics. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines9080875","journal-title":"Biomedicines"},{"key":"6192_CR73","doi-asserted-by":"publisher","unstructured":"Zhu C, Zheng M, Ali U, Xia Q, Wang Z, Chenlong et al (2021) Association between abundance of Haemophilus in the gut microbiota and negative symptoms of schizophrenia. Front Psych 12:685910. https:\/\/doi.org\/10.3389\/fpsyt.2021.685910","DOI":"10.3389\/fpsyt.2021.685910"},{"key":"6192_CR74","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1038\/s41380-022-01456-3","volume":"27","author":"AJ McGuinness","year":"2022","unstructured":"McGuinness AJ, Davis JA, Dawson SL, Loughman A, Collier F, O\u2019Hely M et al (2022) A systematic review of gut microbiota composition in observational studies of major depressive disorder, bipolar disorder and schizophrenia. Mol Psychiatry 27:1920\u20131935. https:\/\/doi.org\/10.1038\/s41380-022-01456-3","journal-title":"Mol Psychiatry"},{"key":"6192_CR75","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2607817","volume":"18","author":"Z Huang","year":"2026","unstructured":"Huang Z, Huang Z, Du Z, Gao X, Jiang Y, Zhou Z et al (2026) Role and mechanism of gut microbiota and metabolites in schizophrenia complicated with sleep disorder. Gut Microbes 18:2607817. https:\/\/doi.org\/10.1080\/19490976.2025.2607817","journal-title":"Gut Microbes"},{"key":"6192_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-89166-8","volume":"11","author":"S Li","year":"2021","unstructured":"Li S, Song J, Ke P, Kong L, Lei B, Zhou J et al (2021) The gut microbiome is associated with brain structure and function in schizophrenia. Sci Rep 11:9743. https:\/\/doi.org\/10.1038\/s41598-021-89166-8","journal-title":"Sci Rep"},{"key":"6192_CR77","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.bbi.2020.10.003","volume":"91","author":"TT Nguyen","year":"2021","unstructured":"Nguyen TT, Kosciolek T, Daly RE, Vazquez-Baeza Y, Swafford A, Knight R et al (2021) Gut microbiome in schizophrenia: altered functional pathways related to immune modulation and atherosclerotic risk. Brain Behav Immun 91:245\u2013256. https:\/\/doi.org\/10.1016\/j.bbi.2020.10.003","journal-title":"Brain Behav Immun"},{"key":"6192_CR78","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1038\/s41467-020-15457-9","volume":"11","author":"F Zhu","year":"2020","unstructured":"Zhu F, Ju Y, Wang W, Wang Q, Guo R, Ma Q et al (2020) Metagenome-wide association of gut microbiome features for schizophrenia. Nat Commun 11:1612. https:\/\/doi.org\/10.1038\/s41467-020-15457-9","journal-title":"Nat Commun"},{"key":"6192_CR79","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.9574","volume":"8","author":"S Li","year":"2020","unstructured":"Li S, Zhuo M, Huang X, Huang Y, Zhou J, Xiong D et al (2020) Altered gut microbiota associated with symptom severity in schizophrenia. PeerJ 8:e9574. https:\/\/doi.org\/10.7717\/peerj.9574","journal-title":"PeerJ"},{"key":"6192_CR80","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aau8317","volume":"5","author":"P Zheng","year":"2019","unstructured":"Zheng P, Zeng B, Liu M, Chen J, Pan J, Han Y et al (2019) The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice. Sci Adv 5:eaau8317. https:\/\/doi.org\/10.1126\/sciadv.aau8317","journal-title":"Sci Adv"},{"key":"6192_CR81","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1093\/schbul\/sbad049","volume":"49","author":"N Murray","year":"2023","unstructured":"Murray N, Al Khalaf S, Bastiaanssen TFS, Kaulmann D, Lonergan E, Cryan JF et al (2023) Compositional and functional alterations in intestinal microbiota in patients with psychosis or schizophrenia: a systematic review and meta-analysis. Schizophr Bull 49:1239\u20131255. https:\/\/doi.org\/10.1093\/schbul\/sbad049","journal-title":"Schizophr Bull"},{"key":"6192_CR82","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/epi4.12461","volume":"6","author":"S Chatzikonstantinou","year":"2021","unstructured":"Chatzikonstantinou S, Gioula G, Kimiskidis VK, McKenna J, Mavroudis I, Kazis D (2021) The gut microbiome in drug-resistant epilepsy. Epilepsia Open 6:28\u201337. https:\/\/doi.org\/10.1002\/epi4.12461","journal-title":"Epilepsia Open"},{"key":"6192_CR83","doi-asserted-by":"publisher","first-page":"5576","DOI":"10.3390\/ijms22115576","volume":"22","author":"J Amlerova","year":"2021","unstructured":"Amlerova J, Sroubek J, Angelucci F, Hort J (2021) Evidences for a role of gut microbiota in pathogenesis and management of epilepsy. Int J Mol Sci 22:5576. https:\/\/doi.org\/10.3390\/ijms22115576","journal-title":"Int J Mol Sci"},{"key":"6192_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104576","volume":"135","author":"GR Lum","year":"2020","unstructured":"Lum GR, Olson CA, Hsiao EY (2020) Emerging roles for the intestinal microbiome in epilepsy. Neurobiol Dis 135:104576. https:\/\/doi.org\/10.1016\/j.nbd.2019.104576","journal-title":"Neurobiol Dis"},{"key":"6192_CR85","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/epi4.12114","volume":"3","author":"JS Medel-Matus","year":"2018","unstructured":"Medel-Matus JS, Shin D, Dorfman E, Sankar R, Mazarati A (2018) Facilitation of kindling epileptogenesis by chronic stress may be mediated by intestinal microbiome. Epilepsia Open 3:290\u2013294. https:\/\/doi.org\/10.1002\/epi4.12114","journal-title":"Epilepsia Open"},{"key":"6192_CR86","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-50542-0","volume":"9","author":"C De Caro","year":"2019","unstructured":"De Caro C, Leo A, Nesci V, Ghelardini C, di Cesare Mannelli L, Striano P et al (2019) Intestinal inflammation increases convulsant activity and reduces antiepileptic drug efficacy in a mouse model of epilepsy. Sci Rep 9:13983. https:\/\/doi.org\/10.1038\/s41598-019-50542-0","journal-title":"Sci Rep"},{"key":"6192_CR87","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/nature22075","volume":"545","author":"AT Tang","year":"2017","unstructured":"Tang AT, Choi JP, Kotzin JJ, Yang Y, Hong CC, Hobson N et al (2017) Endothelial TLR4 and the microbiome drive cerebral cavernous malformations. Nature 545:305\u2013310. https:\/\/doi.org\/10.1038\/nature22075","journal-title":"Nature"},{"key":"6192_CR88","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1111\/epi.16744","volume":"61","author":"M Holmes","year":"2020","unstructured":"Holmes M, Flaminio Z, Vardhan M, Xu F, Li X, Devinsky O et al (2020) Cross talk between drug-resistant epilepsy and the gut microbiome. Epilepsia 61:2619\u201328. https:\/\/doi.org\/10.1111\/epi.16744","journal-title":"Epilepsia"},{"key":"6192_CR89","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.eplepsyres.2018.06.015","volume":"145","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Zhou S, Zhou Y, Yu L, Zhang L, Wang Y (2018) Altered gut microbiome composition in children with refractory epilepsy after ketogenic diet. Epilepsy Res 145:163\u2013168. https:\/\/doi.org\/10.1016\/j.eplepsyres.2018.06.015","journal-title":"Epilepsy Res"},{"key":"6192_CR90","doi-asserted-by":"publisher","DOI":"10.1093\/nutrit\/nuaf311","author":"TG Barros","year":"2026","unstructured":"Barros TG, Modesto JV, Paula MC, Rodrigues RR, Menegusse RB, Miranda VP et al (2026) The interplay between ketogenic diet and the microbiota-gut-brain axis in drug-resistant epilepsy: a systematic review. Nutr Rev. https:\/\/doi.org\/10.1093\/nutrit\/nuaf311","journal-title":"Nutr Rev"},{"key":"6192_CR91","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.1007\/s44411-025-00368-2","volume":"126","author":"MO Oyowvi","year":"2025","unstructured":"Oyowvi MO, Ajayi AF, Comfort OO (2025) Ketogenic diet impacts epilepsy via alterations in gut microbiome composition: a review. Bratisl Med J 126:3290\u20133300. https:\/\/doi.org\/10.1007\/s44411-025-00368-2","journal-title":"Bratisl Med J"},{"issue":"1728\u201341","key":"6192_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.06.051","volume":"173","author":"CA Olson","year":"2018","unstructured":"Olson CA, Vuong HE, Yano JM, Liang QY, Nusbaum DJ, Hsiao EY (2018) The gut microbiota mediates the anti-seizure effects of the ketogenic diet. Cell 173(1728\u201341):e13. https:\/\/doi.org\/10.1016\/j.cell.2018.06.051","journal-title":"Cell"},{"key":"6192_CR93","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s43657-025-00228-7","volume":"5","author":"M Tang","year":"2025","unstructured":"Tang M, Zhang Z, Lin L, Niu J, Meng G, Wang W et al (2025) Comparative analysis of growth dynamics and relative abundances of gut microbiota influenced by ketogenic diet. Phenomics 5:65\u201375. https:\/\/doi.org\/10.1007\/s43657-025-00228-7","journal-title":"Phenomics"},{"key":"6192_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms13112539","volume":"13","author":"M Tang","year":"2025","unstructured":"Tang M, Wang W, Wang J, Wang Y (2025) Alteration of gut microbiota by ketogenic diet as an alternative therapeutic target for drug-resistant epilepsy. Microorganisms 13:2539. https:\/\/doi.org\/10.3390\/microorganisms13112539","journal-title":"Microorganisms"},{"key":"6192_CR95","doi-asserted-by":"publisher","first-page":"326","DOI":"10.22037\/ghfbb.v15i4.2600","volume":"15","author":"L Rew","year":"2022","unstructured":"Rew L, Harris MD, Goldie J (2022) The ketogenic diet: its impact on human gut microbiota and potential consequent health outcomes: a systematic literature review. Gastroenterol Hepatol Bed Bench 15:326\u2013342. https:\/\/doi.org\/10.22037\/ghfbb.v15i4.2600","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"6192_CR96","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1480022","volume":"15","author":"X He","year":"2024","unstructured":"He X, Zhang Y (2024) Changes in gut flora in patients with epilepsy: a systematic review and meta-analysis. Front Microbiol 15:1480022. https:\/\/doi.org\/10.3389\/fmicb.2024.1480022","journal-title":"Front Microbiol"},{"key":"6192_CR97","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/S0140-6736(21)00359-7","volume":"397","author":"BW Penninx","year":"2021","unstructured":"Penninx BW, Pine DS, Holmes EA, Reif A (2021) Anxiety disorders. Lancet 397:914\u2013927. https:\/\/doi.org\/10.1016\/S0140-6736(21)00359-7","journal-title":"Lancet"},{"key":"6192_CR98","doi-asserted-by":"publisher","first-page":"1561916","DOI":"10.3389\/fpsyt.2025.1561916","volume":"16","author":"A Pe\u00e7anha","year":"2025","unstructured":"Pe\u00e7anha A, Silveira B, Krahe TE, Landeira Fernandez J (2025) Can social isolation alleviate symptoms of anxiety and depression disorders? Front Psychiatry 16:1561916. https:\/\/doi.org\/10.3389\/fpsyt.2025.1561916","journal-title":"Front Psychiatry"},{"key":"6192_CR99","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/s42003-021-02249-0","volume":"4","author":"AC Ericsson","year":"2021","unstructured":"Ericsson AC, Hart ML, Kwan J, Lanoue L, Bower LR, Araiza R et al (2021) Supplier-origin mouse microbiomes significantly influence locomotor and anxiety-related behavior, body morphology, and metabolism. Commun Biol 4:716. https:\/\/doi.org\/10.1038\/s42003-021-02249-0","journal-title":"Commun Biol"},{"key":"6192_CR100","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jpsychires.2018.07.007","volume":"104","author":"HY Jiang","year":"2018","unstructured":"Jiang HY, Zhang X, Yu ZH, Zhang Z, Deng M, Zhao JH et al (2018) Altered gut microbiota profile in patients with generalized anxiety disorder. J Psychiatr Res 104:130\u2013136. https:\/\/doi.org\/10.1016\/j.jpsychires.2018.07.007","journal-title":"J Psychiatr Res"},{"key":"6192_CR101","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines6040113","author":"E Huang","year":"2018","unstructured":"Huang E, Kang S, Park H, Park S, Ji Y, Holzapfel WH (2018) Differences in anxiety levels of various murine models in relation to the gut microbiota composition. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines6040113","journal-title":"Biomedicines"},{"key":"6192_CR102","doi-asserted-by":"publisher","DOI":"10.3390\/nu17060933","author":"K Nikel","year":"2025","unstructured":"Nikel K, Stojko M, Smolarczyk J, Piegza M (2025) The impact of gut microbiota on the development of anxiety symptoms-a narrative review. Nutrients. https:\/\/doi.org\/10.3390\/nu17060933","journal-title":"Nutrients"},{"key":"6192_CR103","doi-asserted-by":"publisher","first-page":"1768891","DOI":"10.3389\/fmicb.2026.1768891","volume":"17","author":"H Shen","year":"2026","unstructured":"Shen H, Wang SY, Zhao YY, Zhou JL, Zhao J, Zhu WK (2026) Brain-gut-microbiota axis: a review on the bidirectional regulatory mechanisms between gut microbiota and brain and their disease interactions. Front Microbiol 17:1768891. https:\/\/doi.org\/10.3389\/fmicb.2026.1768891","journal-title":"Front Microbiol"},{"key":"6192_CR104","doi-asserted-by":"publisher","first-page":"8698","DOI":"10.1080\/10408398.2022.2057416","volume":"63","author":"R Kimble","year":"2023","unstructured":"Kimble R, Gouinguenet P, Ashor A, Stewart C, Deighton K, Matu J et al (2023) Effects of a Mediterranean diet on the gut microbiota and microbial metabolites: a systematic review of randomized controlled trials and observational studies. Crit Rev Food Sci Nutr 63:8698\u2013719. https:\/\/doi.org\/10.1080\/10408398.2022.2057416","journal-title":"Crit Rev Food Sci Nutr"},{"key":"6192_CR105","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/nrn2421","volume":"9","author":"F Gomez-Pinilla","year":"2008","unstructured":"Gomez-Pinilla F (2008) Brain foods: the effects of nutrients on brain function. Nat Rev Neurosci 9:568\u2013578. https:\/\/doi.org\/10.1038\/nrn2421","journal-title":"Nat Rev Neurosci"},{"key":"6192_CR106","doi-asserted-by":"publisher","first-page":"5558","DOI":"10.3390\/app15105558","volume":"15","author":"D Koumpouli","year":"2025","unstructured":"Koumpouli D, Koumpouli V, Koutelidakis AE (2025) The gut\u2013brain axis and neurodegenerative diseases: the role of nutritional interventions targeting the gut microbiome\u2014a systematic review. Appl Sci 15:5558. https:\/\/doi.org\/10.3390\/app15105558","journal-title":"Appl Sci"},{"key":"6192_CR107","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.arr.2007.08.004","volume":"7","author":"MP Mattson","year":"2008","unstructured":"Mattson MP (2008) Dietary factors, hormesis and health. Ageing Res Rev 7:43\u201348. https:\/\/doi.org\/10.1016\/j.arr.2007.08.004","journal-title":"Ageing Res Rev"},{"key":"6192_CR108","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s13668-025-00619-2","volume":"14","author":"L Clerici","year":"2025","unstructured":"Clerici L, Bottari D, Bottari B (2025) Gut microbiome, diet and depression: literature review of microbiological, nutritional and neuroscientific aspects. Curr Nutr Rep 14:30. https:\/\/doi.org\/10.1007\/s13668-025-00619-2","journal-title":"Curr Nutr Rep"},{"key":"6192_CR109","doi-asserted-by":"publisher","DOI":"10.3390\/nu15122749","volume":"15","author":"VJ Clemente-Suarez","year":"2023","unstructured":"Clemente-Suarez VJ, Beltran-Velasco AI, Redondo-Florez L, Martin-Rodriguez A, Tornero-Aguilera JF (2023) Global impacts of western diet and its effects on metabolism and health: a narrative review. Nutrients 15:2749. https:\/\/doi.org\/10.3390\/nu15122749","journal-title":"Nutrients"},{"key":"6192_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2024.101923","volume":"72","author":"A Severino","year":"2024","unstructured":"Severino A, Tohumcu E, Tamai L, Dargenio P, Porcari S, Rondinella D et al (2024) The microbiome-driven impact of western diet in the development of noncommunicable chronic disorders. Best Pract Res Clin Gastroenterol 72:101923. https:\/\/doi.org\/10.1016\/j.bpg.2024.101923","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"6192_CR111","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2020.583608","volume":"7","author":"M Bailen","year":"2020","unstructured":"Bailen M, Bressa C, Martinez-Lopez S, Gonzalez-Soltero R, Montalvo Lominchar MG, San Juan C et al (2020) Microbiota features associated with a high-fat\/low-fiber diet in healthy adults. Front Nutr 7:583608. https:\/\/doi.org\/10.3389\/fnut.2020.583608","journal-title":"Front Nutr"},{"key":"6192_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.107615","volume":"212","author":"M Song","year":"2025","unstructured":"Song M, Bai Y, Song F (2025) High-fat diet and neuroinflammation: the role of mitochondria. Pharmacol Res 212:107615. https:\/\/doi.org\/10.1016\/j.phrs.2025.107615","journal-title":"Pharmacol Res"},{"key":"6192_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.105905","volume":"26","author":"GG Kang","year":"2023","unstructured":"Kang GG, Trevaskis NL, Murphy AJ, Febbraio MA (2023) Diet-induced gut dysbiosis and inflammation: key drivers of obesity-driven NASH. iScience 26:105905. https:\/\/doi.org\/10.1016\/j.isci.2022.105905","journal-title":"iScience"},{"key":"6192_CR114","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.691136","volume":"15","author":"SK Lotz","year":"2021","unstructured":"Lotz SK, Blackhurst BM, Reagin KL, Funk KE (2021) Microbial infections are a risk factor for neurodegenerative diseases. Front Cell Neurosci 15:691136. https:\/\/doi.org\/10.3389\/fncel.2021.691136","journal-title":"Front Cell Neurosci"},{"key":"6192_CR115","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.3390\/nu16203570","volume":"16","author":"E Mlynarska","year":"2024","unstructured":"Mlynarska E, Jakubowska P, Frak W, Gajewska A, Sornowska J, Skwira S et al (2024) Associations of microbiota and nutrition with cognitive impairment in diseases. Nutrients 16:3570. https:\/\/doi.org\/10.3390\/nu16203570","journal-title":"Nutrients"},{"key":"6192_CR116","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2323752","volume":"16","author":"G Park","year":"2024","unstructured":"Park G, Kadyan S, Hochuli N, Pollak J, Wang B, Salazar G et al (2024) A modified Mediterranean-style diet enhances brain function via specific gut-microbiome-brain mechanisms. Gut Microbes 16:2323752. https:\/\/doi.org\/10.1080\/19490976.2024.2323752","journal-title":"Gut Microbes"},{"key":"6192_CR117","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.ecofro.2025.02.010","volume":"45","author":"GI Edo","year":"2025","unstructured":"Edo GI, Nwachukwu SC, Akpoghelie PO, Mafe AN, Isoje EF, Igbuku UA et al (2025) An overview of the nutritional composition, bioactivities and applications of Chinese yam (Dioscoreas Oppositae). Ecological Frontiers 45:808\u2013816. https:\/\/doi.org\/10.1016\/j.ecofro.2025.02.010","journal-title":"Ecological Frontiers"},{"key":"6192_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2023.112121","volume":"174","author":"LJ Dominguez","year":"2023","unstructured":"Dominguez LJ, Veronese N, Di Bella G, Cusumano C, Parisi A, Tagliaferri F et al (2023) Mediterranean diet in the management and prevention of obesity. Exp Gerontol 174:112121. https:\/\/doi.org\/10.1016\/j.exger.2023.112121","journal-title":"Exp Gerontol"},{"key":"6192_CR119","doi-asserted-by":"publisher","first-page":"9366","DOI":"10.3390\/ijms25179366","volume":"25","author":"N Randeni","year":"2024","unstructured":"Randeni N, Bordiga M, Xu B (2024) A comprehensive review of the triangular relationship among diet-gut microbiota-inflammation. Int J Mol Sci 25:9366. https:\/\/doi.org\/10.3390\/ijms25179366","journal-title":"Int J Mol Sci"},{"key":"6192_CR120","doi-asserted-by":"publisher","first-page":"1489489","DOI":"10.3389\/fnut.2024.1489489","volume":"11","author":"P Picone","year":"2024","unstructured":"Picone P, Girgenti A, Buttacavoli M, Nuzzo D (2024) Enriching the Mediterranean diet could nourish the brain more effectively. Front Nutr 11:1489489. https:\/\/doi.org\/10.3389\/fnut.2024.1489489","journal-title":"Front Nutr"},{"key":"6192_CR121","doi-asserted-by":"publisher","first-page":"541","DOI":"10.26599\/fshw.2022.9250049","volume":"13","author":"J Zhou","year":"2024","unstructured":"Zhou J, Tang M, Li W, Fang R, Tang C, Wang Q (2024) Diet and physical activity influence the composition of gut microbiota, benefit on Alzheimer\u2019s disease. Food Sci Hum Wellness 13:541\u2013555. https:\/\/doi.org\/10.26599\/fshw.2022.9250049","journal-title":"Food Sci Hum Wellness"},{"key":"6192_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/j.plefa.2023.102572","volume":"192","author":"CF Kelaiditis","year":"2023","unstructured":"Kelaiditis CF, Gibson EL, Dyall SC (2023) Effects of long-chain omega-3 polyunsaturated fatty acids on reducing anxiety and\/or depression in adults; a systematic review and meta-analysis of randomised controlled trials. Prostaglandins Leukot Essent Fatty Acids 192:102572. https:\/\/doi.org\/10.1016\/j.plefa.2023.102572","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"6192_CR123","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1046\/j.1471-4159.2000.0752563.x","volume":"75","author":"T Moriguchi","year":"2000","unstructured":"Moriguchi T, Greiner RS, Salem N Jr (2000) Behavioral deficits associated with dietary induction of decreased brain docosahexaenoic acid concentration. J Neurochem 75:2563\u20132573. https:\/\/doi.org\/10.1046\/j.1471-4159.2000.0752563.x","journal-title":"J Neurochem"},{"key":"6192_CR124","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/s0306-9877(98)90000-7","volume":"50","author":"DF Horrobin","year":"1998","unstructured":"Horrobin DF (1998) Schizophrenia: the illness that made us human. Med Hypotheses 50:269\u2013288. https:\/\/doi.org\/10.1016\/s0306-9877(98)90000-7","journal-title":"Med Hypotheses"},{"key":"6192_CR125","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.4088\/jcp.v67n1217","volume":"67","author":"MP Freeman","year":"2006","unstructured":"Freeman MP, Hibbeln JR, Wisner KL, Davis JM, Mischoulon D, Peet M et al (2006) Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry 67:1954\u20131967. https:\/\/doi.org\/10.4088\/jcp.v67n1217","journal-title":"J Clin Psychiatry"},{"key":"6192_CR126","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.4088\/JCP.11r07546","volume":"73","author":"PY Lin","year":"2012","unstructured":"Lin PY, Chiu CC, Huang SY, Su KP (2012) A meta-analytic review of polyunsaturated fatty acid compositions in dementia. J Clin Psychiatry 73:1245\u20131254. https:\/\/doi.org\/10.4088\/JCP.11r07546","journal-title":"J Clin Psychiatry"},{"key":"6192_CR127","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1093\/ajcn.82.2.281","volume":"82","author":"JC McCann","year":"2005","unstructured":"McCann JC, Ames BN (2005) Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals. Am J Clin Nutr 82:281\u2013295. https:\/\/doi.org\/10.1093\/ajcn.82.2.281","journal-title":"Am J Clin Nutr"},{"key":"6192_CR128","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.nutres.2015.03.002","volume":"35","author":"C He","year":"2015","unstructured":"He C, Shan Y, Song W (2015) Targeting gut microbiota as a possible therapy for diabetes. Nutr Res 35:361\u2013367. https:\/\/doi.org\/10.1016\/j.nutres.2015.03.002","journal-title":"Nutr Res"},{"key":"6192_CR129","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.3390\/ijerph19031208","volume":"19","author":"G Precup","year":"2022","unstructured":"Precup G, Pocol CB, Teleky BE, Vodnar DC (2022) Awareness, knowledge, and interest about prebiotics-a study among romanian consumers. Int J Environ Res Public Health 19:1208. https:\/\/doi.org\/10.3390\/ijerph19031208","journal-title":"Int J Environ Res Public Health"},{"key":"6192_CR130","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.712531","volume":"12","author":"G Divyashri","year":"2021","unstructured":"Divyashri G, Sadanandan B, Chidambara Murthy KN, Shetty K, Mamta K (2021) Neuroprotective potential of non-digestible oligosaccharides: an overview of experimental evidence. Front Pharmacol 12:712531. https:\/\/doi.org\/10.3389\/fphar.2021.712531","journal-title":"Front Pharmacol"},{"key":"6192_CR131","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103092","volume":"71","author":"B Kalyanaraman","year":"2024","unstructured":"Kalyanaraman B, Cheng G, Hardy M (2024) Gut microbiome, short-chain fatty acids, alpha-synuclein, neuroinflammation, and ROS\/RNS: relevance to Parkinson\u2019s disease and therapeutic implications. Redox Biol 71:103092. https:\/\/doi.org\/10.1016\/j.redox.2024.103092","journal-title":"Redox Biol"},{"key":"6192_CR132","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","volume":"4","author":"JW Kinney","year":"2018","unstructured":"Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT (2018) Inflammation as a central mechanism in Alzheimer\u2019s disease. Alzheimers Dement (N Y) 4:575\u2013590. https:\/\/doi.org\/10.1016\/j.trci.2018.06.014","journal-title":"Alzheimers Dement (N Y)"},{"key":"6192_CR133","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000018608","volume":"99","author":"W Li","year":"2020","unstructured":"Li W, Guo J, Shen Y, Huang L, Leng B, Fan D et al (2020) Probiotics, prebiotics, and synbiotics for the treatment of dementia: protocol for a systematic review. Medicine (Baltimore) 99:e18608. https:\/\/doi.org\/10.1097\/MD.0000000000018608","journal-title":"Medicine (Baltimore)"},{"key":"6192_CR134","doi-asserted-by":"publisher","first-page":"345","DOI":"10.2147\/JIR.S174982","volume":"11","author":"QX Ng","year":"2018","unstructured":"Ng QX, Soh AYS, Loke W, Lim DY, Yeo WS (2018) The role of inflammation in irritable bowel syndrome (IBS). J Inflamm Res 11:345\u2013349. https:\/\/doi.org\/10.2147\/JIR.S174982","journal-title":"J Inflamm Res"},{"key":"6192_CR135","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/628192","volume":"2015","author":"NP Rocha","year":"2015","unstructured":"Rocha NP, de Miranda AS, Teixeira AL (2015) Insights into neuroinflammation in Parkinson\u2019s disease: from biomarkers to anti-inflammatory based therapies. Biomed Res Int 2015:628192. https:\/\/doi.org\/10.1155\/2015\/628192","journal-title":"Biomed Res Int"},{"key":"6192_CR136","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/ph11020056","volume":"11","author":"D Siniscalco","year":"2018","unstructured":"Siniscalco D, Schultz S, Brigida AL, Antonucci N (2018) Inflammation and neuro-immune dysregulations in autism spectrum disorders. Pharmaceuticals (Basel) 11:56. https:\/\/doi.org\/10.3390\/ph11020056","journal-title":"Pharmaceuticals (Basel)"},{"key":"6192_CR137","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.biopsych.2016.12.031","volume":"82","author":"A Burokas","year":"2017","unstructured":"Burokas A, Arboleya S, Moloney RD, Peterson VL, Murphy K, Clarke G et al (2017) Targeting the microbiota-gut-brain axis: prebiotics have anxiolytic and antidepressant-like effects and reverse the impact of chronic stress in mice. Biol Psychiatry 82:472\u2013487. https:\/\/doi.org\/10.1016\/j.biopsych.2016.12.031","journal-title":"Biol Psychiatry"},{"key":"6192_CR138","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.670500","volume":"12","author":"S Westfall","year":"2021","unstructured":"Westfall S, Caracci F, Estill M, Frolinger T, Shen L, Pasinetti GM (2021) Chronic stress-induced depression and anxiety priming modulated by gut-brain-axis immunity. Front Immunol 12:670500. https:\/\/doi.org\/10.3389\/fimmu.2021.670500","journal-title":"Front Immunol"},{"key":"6192_CR139","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12871-018-0642-1","volume":"18","author":"XD Yang","year":"2018","unstructured":"Yang XD, Wang LK, Wu HY, Jiao L (2018) Effects of prebiotic galacto-oligosaccharide on postoperative cognitive dysfunction and neuroinflammation through targeting of the gut-brain axis. BMC Anesthesiol 18:177. https:\/\/doi.org\/10.1186\/s12871-018-0642-1","journal-title":"BMC Anesthesiol"},{"key":"6192_CR140","doi-asserted-by":"publisher","DOI":"10.1186\/s40064-015-1565-7","volume":"4","author":"P Pangsri","year":"2015","unstructured":"Pangsri P, Piwpankaew Y, Ingkakul A, Nitisinprasert S, Keawsompong S (2015) Characterization of mannanase from Bacillus circulans NT 6.7 and its application in mannooligosaccharides preparation as prebiotic. Springerplus 4:771. https:\/\/doi.org\/10.1186\/s40064-015-1565-7","journal-title":"Springerplus"},{"key":"6192_CR141","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.bbi.2021.04.005","volume":"95","author":"Q Liu","year":"2021","unstructured":"Liu Q, Xi Y, Wang Q, Liu J, Li P, Meng X et al (2021) Mannan oligosaccharide attenuates cognitive and behavioral disorders in the 5xFAD Alzheimer\u2019s disease mouse model via regulating the gut microbiota-brain axis. Brain Behav Immun 95:330\u2013343. https:\/\/doi.org\/10.1016\/j.bbi.2021.04.005","journal-title":"Brain Behav Immun"},{"key":"6192_CR142","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.1039\/c8fo00209f","volume":"9","author":"H Wang","year":"2018","unstructured":"Wang H, Zhang X, Wang S, Li H, Lu Z, Shi J et al (2018) Mannan-oligosaccharide modulates the obesity and gut microbiota in high-fat diet-fed mice. Food Funct 9:3916\u20133929. https:\/\/doi.org\/10.1039\/c8fo00209f","journal-title":"Food Funct"},{"key":"6192_CR143","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodres.2022.111067","volume":"155","author":"X Liu","year":"2022","unstructured":"Liu X, Du ZR, Wang X, Sun XR, Zhao Q, Zhao F et al (2022) Polymannuronic acid prebiotic plus Lacticaseibacillus rhamnosus GG probiotic as a novel synbiotic promoted their separate neuroprotection against Parkinson\u2019s disease. Food Res Int 155:111067. https:\/\/doi.org\/10.1016\/j.foodres.2022.111067","journal-title":"Food Res Int"},{"key":"6192_CR144","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/JCP.0000000000001364","volume":"41","author":"DL Kelly","year":"2021","unstructured":"Kelly DL, Kane MA, Fraser CM, Sayer MA, Grant-Beurmann S, Liu T et al (2021) Prebiotic treatment increases serum butyrate in people with schizophrenia: results of an open-label inpatient pilot clinical trial. J Clin Psychopharmacol 41:200\u2013202. https:\/\/doi.org\/10.1097\/JCP.0000000000001364","journal-title":"J Clin Psychopharmacol"},{"key":"6192_CR145","first-page":"305","volume":"24","author":"Y Ido","year":"2017","unstructured":"Ido Y, Nagamine T, Okamura T, Tasaki M, Fukuo K (2017) Prebiotic lactosucrose may improve not only constipation but also psychotic symptoms of Schizophrenia. Int Med J 24:305\u2013306","journal-title":"Int Med J"},{"issue":"Suppl 2","key":"6192_CR146","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1017\/S0007114510003363","volume":"104","author":"M Roberfroid","year":"2010","unstructured":"Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, Rowland I et al (2010) Prebiotic effects: metabolic and health benefits. Br J Nutr 104(Suppl 2):S1-63. https:\/\/doi.org\/10.1017\/S0007114510003363","journal-title":"Br J Nutr"},{"key":"6192_CR147","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2025.115789","volume":"495","author":"S Sal-Sarria","year":"2025","unstructured":"Sal-Sarria S, Burnet PWJ (2025) Early-life cognitive effects of prebiotics and probiotics: a cross-species systematic review. Behav Brain Res 495:115789. https:\/\/doi.org\/10.1016\/j.bbr.2025.115789","journal-title":"Behav Brain Res"},{"key":"6192_CR148","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105840","volume":"172","author":"K Socala","year":"2021","unstructured":"Socala K, Doboszewska U, Szopa A, Serefko A, Wlodarczyk M, Zielinska A et al (2021) The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders. Pharmacol Res 172:105840. https:\/\/doi.org\/10.1016\/j.phrs.2021.105840","journal-title":"Pharmacol Res"},{"key":"6192_CR149","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3390\/nu18030372","volume":"18","author":"C Monteiro","year":"2026","unstructured":"Monteiro C, Bogea EG, Campos CDL, Pereira-Filho JL, Almeida VSS, Vale AAM et al (2026) Prebiotics and gut health: mechanisms, clinical evidence, and future directions. Nutrients 18:372. https:\/\/doi.org\/10.3390\/nu18030372","journal-title":"Nutrients"},{"key":"6192_CR150","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.3390\/microorganisms11041083","volume":"11","author":"S Ojha","year":"2023","unstructured":"Ojha S, Patil N, Jain M, Kole C, Kaushik P (2023) Probiotics for neurodegenerative diseases: a systemic review. Microorganisms 11:1083. https:\/\/doi.org\/10.3390\/microorganisms11041083","journal-title":"Microorganisms"},{"key":"6192_CR151","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2431643","volume":"16","author":"AB Shah","year":"2024","unstructured":"Shah AB, Baiseitova A, Zahoor M, Ahmad I, Ikram M, Bakhsh A et al (2024) Probiotic significance of Lactobacillus strains: a comprehensive review on health impacts, research gaps, and future prospects. Gut Microbes 16:2431643. https:\/\/doi.org\/10.1080\/19490976.2024.2431643","journal-title":"Gut Microbes"},{"key":"6192_CR152","doi-asserted-by":"publisher","first-page":"1348297","DOI":"10.3389\/fphar.2024.134829","volume":"15","author":"A Kumar","year":"2024","unstructured":"Kumar A, Sivamaruthi BS, Dey S, Kumar Y, Malviya R, Prajapati BG et al (2024) Probiotics as modulators of gut-brain axis for cognitive development. Front Pharmacol 15:1348297. https:\/\/doi.org\/10.3389\/fphar.2024.134829","journal-title":"Front Pharmacol"},{"key":"6192_CR153","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1002\/eji.200838855","volume":"38","author":"S Gordon","year":"2008","unstructured":"Gordon S (2008) Elie Metchnikoff: father of natural immunity. Eur J Immunol 38:3257\u20133264. https:\/\/doi.org\/10.1002\/eji.200838855","journal-title":"Eur J Immunol"},{"key":"6192_CR154","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.tim.2021.01.003","volume":"29","author":"M Cunningham","year":"2021","unstructured":"Cunningham M, Azcarate-Peril MA, Barnard A, Benoit V, Grimaldi R, Guyonnet D et al (2021) Shaping the future of probiotics and prebiotics. Trends Microbiol 29:667\u2013685. https:\/\/doi.org\/10.1016\/j.tim.2021.01.003","journal-title":"Trends Microbiol"},{"key":"6192_CR155","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.tifs.2019.11.022","volume":"95","author":"A Mousavi Khaneghah","year":"2020","unstructured":"Mousavi Khaneghah A, Abhari K, E\u015f I, Soares MB, Oliveira RBA, Hosseini H et al (2020) Interactions between probiotics and pathogenic microorganisms in hosts and foods: a review. Trends Food Sci Technol 95:205\u2013218. https:\/\/doi.org\/10.1016\/j.tifs.2019.11.022","journal-title":"Trends Food Sci Technol"},{"key":"6192_CR156","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.959941","volume":"9","author":"M Idrees","year":"2022","unstructured":"Idrees M, Imran M, Atiq N, Zahra R, Abid R, Alreshidi M et al (2022) Probiotics, their action modality and the use of multi-omics in metamorphosis of commensal microbiota into target-based probiotics. Front Nutr 9:959941. https:\/\/doi.org\/10.3389\/fnut.2022.959941","journal-title":"Front Nutr"},{"key":"6192_CR157","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1111\/j.1582-4934.2009.00686.x","volume":"13","author":"WA Kunze","year":"2009","unstructured":"Kunze WA, Mao YK, Wang B, Huizinga JD, Ma X, Forsythe P et al (2009) Lactobacillus reuteri enhances excitability of colonic AH neurons by inhibiting calcium-dependent potassium channel opening. J Cell Mol Med 13:2261\u20132270. https:\/\/doi.org\/10.1111\/j.1582-4934.2009.00686.x","journal-title":"J Cell Mol Med"},{"key":"6192_CR158","doi-asserted-by":"publisher","DOI":"10.3390\/nu16010016","volume":"16","author":"YC Hsu","year":"2023","unstructured":"Hsu YC, Huang YY, Tsai SY, Kuo YW, Lin JH, Ho HH et al (2023) Efficacy of probiotic supplements on brain-derived neurotrophic factor, inflammatory biomarkers, oxidative stress and cognitive function in patients with Alzheimer\u2019s dementia: a 12-week randomized, double-blind active-controlled study. Nutrients 16:16. https:\/\/doi.org\/10.3390\/nu16010016","journal-title":"Nutrients"},{"key":"6192_CR159","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1038\/s41598-017-02587-2","volume":"7","author":"L Bonfili","year":"2017","unstructured":"Bonfili L, Cecarini V, Berardi S, Scarpona S, Suchodolski JS, Nasuti C et al (2017) Microbiota modulation counteracts Alzheimer\u2019s disease progression influencing neuronal proteolysis and gut hormones plasma levels. Sci Rep 7:2426. https:\/\/doi.org\/10.1038\/s41598-017-02587-2","journal-title":"Sci Rep"},{"key":"6192_CR160","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-13368-2","volume":"7","author":"Y Kobayashi","year":"2017","unstructured":"Kobayashi Y, Sugahara H, Shimada K, Mitsuyama E, Kuhara T, Yasuoka A et al (2017) Therapeutic potential of Bifidobacterium breve strain A1 for preventing cognitive impairment in Alzheimer\u2019s disease. Sci Rep 7:13510. https:\/\/doi.org\/10.1038\/s41598-017-13368-2","journal-title":"Sci Rep"},{"key":"6192_CR161","doi-asserted-by":"publisher","first-page":"8153","DOI":"10.2147\/JIR.S511931","volume":"18","author":"X Yu","year":"2025","unstructured":"Yu X, Yu X, Yang Y, Cheng W, Shi M, Chen L et al (2025) Probiotic Bifico ameliorates depression- and anxiety-like behaviors induced by estrogen deficiency via NLRP3 inflammasome inhibition. J Inflamm Res 18:8153\u20138171. https:\/\/doi.org\/10.2147\/JIR.S511931","journal-title":"J Inflamm Res"},{"key":"6192_CR162","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.bbi.2021.11.023","volume":"100","author":"P Tian","year":"2022","unstructured":"Tian P, Chen Y, Zhu H, Wang L, Qian X, Zou R et al (2022) Bifidobacterium breve CCFM1025 attenuates major depression disorder via regulating gut microbiome and tryptophan metabolism: a randomized clinical trial. Brain Behav Immun 100:233\u2013241. https:\/\/doi.org\/10.1016\/j.bbi.2021.11.023","journal-title":"Brain Behav Immun"},{"key":"6192_CR163","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3920\/BM2018.0018","volume":"9","author":"M Gomez-Eguilaz","year":"2018","unstructured":"Gomez-Eguilaz M, Ramon-Trapero JL, Perez-Martinez L, Blanco JR (2018) The beneficial effect of probiotics as a supplementary treatment in drug-resistant epilepsy: a pilot study. Benef Microbes 9:875\u2013881. https:\/\/doi.org\/10.3920\/BM2018.0018","journal-title":"Benef Microbes"},{"key":"6192_CR164","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jad.2018.11.011","volume":"245","author":"R Okubo","year":"2019","unstructured":"Okubo R, Koga M, Katsumata N, Odamaki T, Matsuyama S, Oka M et al (2019) Effect of bifidobacterium breve A-1 on anxiety and depressive symptoms in schizophrenia: a proof-of-concept study. J Affect Disord 245:377\u2013385. https:\/\/doi.org\/10.1016\/j.jad.2018.11.011","journal-title":"J Affect Disord"},{"key":"6192_CR165","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2020.537847","volume":"8","author":"K Arora","year":"2020","unstructured":"Arora K, Green M, Prakash S (2020) The microbiome and Alzheimer\u2019s disease: potential and limitations of prebiotic, synbiotic, and probiotic formulations. Front Bioeng Biotechnol 8:537847. https:\/\/doi.org\/10.3389\/fbioe.2020.537847","journal-title":"Front Bioeng Biotechnol"},{"key":"6192_CR166","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1056\/NEJMra041867","volume":"352","author":"EW Boyer","year":"2005","unstructured":"Boyer EW, Shannon M (2005) The serotonin syndrome. N Engl J Med 352:1112\u20131120. https:\/\/doi.org\/10.1056\/NEJMra041867","journal-title":"N Engl J Med"},{"key":"6192_CR167","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/fsn3.3826","volume":"12","author":"N Akram","year":"2024","unstructured":"Akram N, Faisal Z, Irfan R, Shah YA, Batool SA, Zahid T et al (2024) Exploring the serotonin-probiotics-gut health axis: a review of current evidence and potential mechanisms. Food Sci Nutr 12:694\u2013706. https:\/\/doi.org\/10.1002\/fsn3.3826","journal-title":"Food Sci Nutr"},{"key":"6192_CR168","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3389\/fmed.2018.00124","volume":"5","author":"LV McFarland","year":"2018","unstructured":"McFarland LV, Evans CT, Goldstein EJC (2018) Strain-specificity and disease-specificity of probiotic efficacy: a systematic review and meta-analysis. Front Med (Lausanne) 5:124. https:\/\/doi.org\/10.3389\/fmed.2018.00124","journal-title":"Front Med (Lausanne)"},{"key":"6192_CR169","doi-asserted-by":"publisher","first-page":"30","DOI":"10.20524\/aog.2018.0328","volume":"32","author":"D Ramai","year":"2019","unstructured":"Ramai D, Zakhia K, Ofosu A, Ofori E, Reddy M (2019) Fecal microbiota transplantation: donor relation, fresh or frozen, delivery methods, cost-effectiveness. Ann Gastroenterol 32:30\u201338. https:\/\/doi.org\/10.20524\/aog.2018.0328","journal-title":"Ann Gastroenterol"},{"key":"6192_CR170","doi-asserted-by":"publisher","first-page":"630","DOI":"10.7326\/M14-2693","volume":"162","author":"D Drekonja","year":"2015","unstructured":"Drekonja D, Reich J, Gezahegn S, Greer N, Shaukat A, MacDonald R et al (2015) Fecal microbiota transplantation for Clostridium difficile infection: a systematic review. Ann Intern Med 162:630\u2013638. https:\/\/doi.org\/10.7326\/M14-2693","journal-title":"Ann Intern Med"},{"issue":"Suppl 1","key":"6192_CR171","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1016\/j.jfma.2018.08.011","volume":"118","author":"JW Wang","year":"2019","unstructured":"Wang JW, Kuo CH, Kuo FC, Wang YK, Hsu WH, Yu FJ et al (2019) Fecal microbiota transplantation: review and update. J Formos Med Assoc 118(Suppl 1):S23\u2013S31. https:\/\/doi.org\/10.1016\/j.jfma.2018.08.011","journal-title":"J Formos Med Assoc"},{"key":"6192_CR172","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/ajg.2014.133","volume":"109","author":"CR Kelly","year":"2014","unstructured":"Kelly CR, Ihunnah C, Fischer M, Khoruts A, Surawicz C, Afzali A et al (2014) Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. Am J Gastroenterol 109:1065\u20131071. https:\/\/doi.org\/10.1038\/ajg.2014.133","journal-title":"Am J Gastroenterol"},{"key":"6192_CR173","doi-asserted-by":"publisher","first-page":"4866","DOI":"10.1007\/s10620-021-07347-x","volume":"67","author":"K Suchman","year":"2022","unstructured":"Suchman K, Luo Y, Grinspan A (2022) Fecal microbiota transplant for Clostridioides difficile infection is safe and efficacious in an immunocompromised cohort. Dig Dis Sci 67:4866\u20134873. https:\/\/doi.org\/10.1007\/s10620-021-07347-x","journal-title":"Dig Dis Sci"},{"key":"6192_CR174","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-021-01007-y","volume":"9","author":"Y Jing","year":"2021","unstructured":"Jing Y, Yu Y, Bai F, Wang L, Yang D, Zhang C et al (2021) Effect of fecal microbiota transplantation on neurological restoration in a spinal cord injury mouse model: involvement of brain-gut axis. Microbiome 9:59. https:\/\/doi.org\/10.1186\/s40168-021-01007-y","journal-title":"Microbiome"},{"key":"6192_CR175","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.arr.2018.04.004","volume":"45","author":"MF Sun","year":"2018","unstructured":"Sun MF, Shen YQ (2018) Dysbiosis of gut microbiota and microbial metabolites in Parkinson\u2019s disease. Ageing Res Rev 45:53\u201361. https:\/\/doi.org\/10.1016\/j.arr.2018.04.004","journal-title":"Ageing Res Rev"},{"key":"6192_CR176","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13073-022-01148-1","volume":"15","author":"F Thirion","year":"2023","unstructured":"Thirion F, Sellebjerg F, Fan Y, Lyu L, Hansen TH, Pons N et al (2023) The gut microbiota in multiple sclerosis varies with disease activity. Genome Med 15:1. https:\/\/doi.org\/10.1186\/s13073-022-01148-1","journal-title":"Genome Med"},{"key":"6192_CR177","doi-asserted-by":"publisher","first-page":"223","DOI":"10.14310\/horm.2002.1742","volume":"16","author":"Y Kang","year":"2017","unstructured":"Kang Y, Cai Y (2017) Gut microbiota and obesity: implications for fecal microbiota transplantation therapy. Hormones (Athens) 16:223\u2013234. https:\/\/doi.org\/10.14310\/horm.2002.1742","journal-title":"Hormones (Athens)"},{"key":"6192_CR178","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-025-01061-5","volume":"11","author":"M De Sciscio","year":"2025","unstructured":"De Sciscio M, Bryant RV, Haylock-Jacobs S, Day AS, Pitchers W, Iansek R et al (2025) Faecal microbiota transplant in Parkinson\u2019s disease: pilot study to establish safety & tolerability. NPJ Parkinsons Dis 11:203. https:\/\/doi.org\/10.1038\/s41531-025-01061-5","journal-title":"NPJ Parkinsons Dis"},{"key":"6192_CR179","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3390\/cells12010119","volume":"12","author":"S Elangovan","year":"2022","unstructured":"Elangovan S, Borody TJ, Holsinger RMD (2022) Fecal microbiota transplantation reduces pathology and improves cognition in a mouse model of Alzheimer\u2019s disease. Cells 12:119. https:\/\/doi.org\/10.3390\/cells12010119","journal-title":"Cells"},{"key":"6192_CR180","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70259","volume":"31","author":"X Jiang","year":"2025","unstructured":"Jiang X, Zheng Y, Sun H, Dang Y, Yin M, Xiao M et al (2025) Fecal microbiota transplantation improves cognitive function of a mouse model of Alzheimer\u2019s disease. CNS Neurosci Ther 31:e70259. https:\/\/doi.org\/10.1111\/cns.70259","journal-title":"CNS Neurosci Ther"},{"key":"6192_CR181","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2025.e42925","author":"Z Zou","year":"2025","unstructured":"Zou Z, Lei D, Yin Y, Xu R, Luo H, Chen T et al (2025) Frequent fecal microbiota transplantation improves cognitive impairment and pathological changes in Alzheimer\u2019s disease FAD4T mice via the microbiota-gut-brain axis. Heliyon. https:\/\/doi.org\/10.1016\/j.heliyon.2025.e42925","journal-title":"Heliyon"},{"key":"6192_CR182","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jpsychires.2021.02.057","volume":"137","author":"J Rao","year":"2021","unstructured":"Rao J, Qiao Y, Xie R, Lin L, Jiang J, Wang C et al (2021) Fecal microbiota transplantation ameliorates stress-induced depression-like behaviors associated with the inhibition of glial and NLRP3 inflammasome in rat brain. J Psychiatr Res 137:147\u2013157. https:\/\/doi.org\/10.1016\/j.jpsychires.2021.02.057","journal-title":"J Psychiatr Res"},{"key":"6192_CR183","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41398-023-02307-7","volume":"13","author":"J Wang","year":"2023","unstructured":"Wang J, Cao Y, Hou W, Bi D, Yin F, Gao Y et al (2023) Fecal microbiota transplantation improves VPA-induced ASD mice by modulating the serotonergic and glutamatergic synapse signaling pathways. Transl Psychiatry 13:17. https:\/\/doi.org\/10.1038\/s41398-023-02307-7","journal-title":"Transl Psychiatry"},{"key":"6192_CR184","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-016-0225-7","volume":"5","author":"DW Kang","year":"2017","unstructured":"Kang DW, Adams JB, Gregory AC, Borody T, Chittick L, Fasano A et al (2017) Microbiota transfer therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study. Microbiome 5:10. https:\/\/doi.org\/10.1186\/s40168-016-0225-7","journal-title":"Microbiome"},{"key":"6192_CR185","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3389\/fcimb.2020.00098","volume":"10","author":"KEW Vendrik","year":"2020","unstructured":"Vendrik KEW, Ooijevaar RE, de Jong PRC, Laman JD, van Oosten BW, van Hilten JJ et al (2020) Fecal microbiota transplantation in neurological disorders. Front Cell Infect Microbiol 10:98. https:\/\/doi.org\/10.3389\/fcimb.2020.00098","journal-title":"Front Cell Infect Microbiol"},{"key":"6192_CR186","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.coph.2019.04.008","volume":"49","author":"FE Dailey","year":"2019","unstructured":"Dailey FE, Turse EP, Daglilar E, Tahan V (2019) The dirty aspects of fecal microbiota transplantation: a review of its adverse effects and complications. Curr Opin Pharmacol 49:29\u201333. https:\/\/doi.org\/10.1016\/j.coph.2019.04.008","journal-title":"Curr Opin Pharmacol"},{"key":"6192_CR187","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2452277","volume":"17","author":"A Lin","year":"2025","unstructured":"Lin A, Jiang A, Huang L, Li Y, Zhang C, Zhu L et al (2025) From chaos to order: optimizing fecal microbiota transplantation for enhanced immune checkpoint inhibitors efficacy. Gut Microbes 17:2452277. https:\/\/doi.org\/10.1080\/19490976.2025.2452277","journal-title":"Gut Microbes"},{"key":"6192_CR188","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00060-22","volume":"37","author":"A Yadegar","year":"2024","unstructured":"Yadegar A, Bar-Yoseph H, Monaghan TM, Pakpour S, Severino A, Kuijper EJ et al (2024) Fecal microbiota transplantation: current challenges and future landscapes. Clin Microbiol Rev 37:e0006022. https:\/\/doi.org\/10.1128\/cmr.00060-22","journal-title":"Clin Microbiol Rev"},{"key":"6192_CR189","doi-asserted-by":"publisher","DOI":"10.3389\/frmbi.2026.1863308","volume":"5","author":"J Zhao","year":"2026","unstructured":"Zhao J, Fan Y, Yang K, Gao H (2026) Fecal microbiota transplantation: from empirical remedy to precision medicine. Front Microbiomes 5:1863308. https:\/\/doi.org\/10.3389\/frmbi.2026.1863308","journal-title":"Front Microbiomes"},{"key":"6192_CR190","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/femsre\/fuy018","volume":"42","author":"H Neuman","year":"2018","unstructured":"Neuman H, Forsythe P, Uzan A, Avni O, Koren O (2018) Antibiotics in early life: dysbiosis and the damage done. FEMS Microbiol Rev 42:489\u2013499. https:\/\/doi.org\/10.1093\/femsre\/fuy018","journal-title":"FEMS Microbiol Rev"},{"key":"6192_CR191","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.bbi.2016.02.020","volume":"56","author":"EE Frohlich","year":"2016","unstructured":"Frohlich EE, Farzi A, Mayerhofer R, Reichmann F, Jacan A, Wagner B et al (2016) Cognitive impairment by antibiotic-induced gut dysbiosis: analysis of gut microbiota-brain communication. Brain Behav Immun 56:140\u2013155. https:\/\/doi.org\/10.1016\/j.bbi.2016.02.020","journal-title":"Brain Behav Immun"},{"key":"6192_CR192","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.bbi.2015.04.004","volume":"48","author":"L Desbonnet","year":"2015","unstructured":"Desbonnet L, Clarke G, Traplin A, O\u2019Sullivan O, Crispie F, Moloney RD et al (2015) Gut microbiota depletion from early adolescence in mice: implications for brain and behaviour. Brain Behav Immun 48:165\u2013173. https:\/\/doi.org\/10.1016\/j.bbi.2015.04.004","journal-title":"Brain Behav Immun"},{"key":"6192_CR193","doi-asserted-by":"publisher","first-page":"13897","DOI":"10.1038\/s41598-018-31764-0","volume":"8","author":"HM Jang","year":"2018","unstructured":"Jang HM, Lee KE, Lee HJ, Kim DH (2018) Immobilization stress-induced Escherichia coli causes anxiety by inducing NF-kappaB activation through gut microbiota disturbance. Sci Rep 8:13897. https:\/\/doi.org\/10.1038\/s41598-018-31764-0","journal-title":"Sci Rep"},{"key":"6192_CR194","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12974-015-0434-1","volume":"12","author":"WA Banks","year":"2015","unstructured":"Banks WA, Gray AM, Erickson MA, Salameh TS, Damodarasamy M, Sheibani N et al (2015) Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit. J Neuroinflammation 12:223. https:\/\/doi.org\/10.1186\/s12974-015-0434-1","journal-title":"J Neuroinflammation"},{"key":"6192_CR195","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.564271","volume":"11","author":"KE Lee","year":"2020","unstructured":"Lee KE, Kim JK, Kim DH (2020) Orally administered antibiotics vancomycin and ampicillin cause cognitive impairment with gut dysbiosis in mice with transient global forebrain ischemia. Front Microbiol 11:564271. https:\/\/doi.org\/10.3389\/fmicb.2020.564271","journal-title":"Front Microbiol"},{"key":"6192_CR196","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2022.160094","volume":"858","author":"D Tian","year":"2023","unstructured":"Tian D, Shi W, Yu Y, Zhou W, Tang Y, Zhang W et al (2023) Enrofloxacin exposure induces anxiety-like behavioral responses in zebrafish by affecting the microbiota-gut-brain axis. Sci Total Environ 858:160094. https:\/\/doi.org\/10.1016\/j.scitotenv.2022.160094","journal-title":"Sci Total Environ"},{"key":"6192_CR197","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s11481-021-10047-y","volume":"18","author":"C Cui","year":"2023","unstructured":"Cui C, Hong H, Shi Y, Zhou Y, Qiao CM, Zhao WJ et al (2023) Vancomycin pretreatment on MPTP-induced Parkinson\u2019s disease mice exerts neuroprotection by suppressing inflammation both in brain and gut. J Neuroimmune Pharmacol 18:72\u201389. https:\/\/doi.org\/10.1007\/s11481-021-10047-y","journal-title":"J Neuroimmune Pharmacol"},{"key":"6192_CR198","doi-asserted-by":"publisher","first-page":"3468","DOI":"10.3390\/cells11213468","volume":"11","author":"CT Hong","year":"2022","unstructured":"Hong CT, Chan L, Chen KY, Lee HH, Huang LK, Yang YSH et al (2022) Rifaximin modifies gut microbiota and attenuates inflammation in Parkinson\u2019s disease: preclinical and clinical studies. Cells 11:3468. https:\/\/doi.org\/10.3390\/cells11213468","journal-title":"Cells"},{"key":"6192_CR199","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.brainresbull.2018.08.015","volume":"143","author":"HY Liu","year":"2018","unstructured":"Liu HY, Yue J, Hu LN, Cheng LF, Wang XS, Wang XJ et al (2018) Chronic minocycline treatment reduces the anxiety-like behaviors induced by repeated restraint stress through modulating neuroinflammation. Brain Res Bull 143:19\u201326. https:\/\/doi.org\/10.1016\/j.brainresbull.2018.08.015","journal-title":"Brain Res Bull"},{"key":"6192_CR200","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.bbi.2020.06.019","volume":"88","author":"B Wang","year":"2020","unstructured":"Wang B, Huang X, Pan X, Zhang T, Hou C, Su WJ et al (2020) Minocycline prevents the depressive-like behavior through inhibiting the release of HMGB1 from microglia and neurons. Brain Behav Immun 88:132\u2013143. https:\/\/doi.org\/10.1016\/j.bbi.2020.06.019","journal-title":"Brain Behav Immun"},{"key":"6192_CR201","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2021.105620","volume":"136","author":"C Meng","year":"2022","unstructured":"Meng C, Feng S, Hao Z, Dong C, Liu H (2022) Antibiotics exposure attenuates chronic unpredictable mild stress-induced anxiety-like and depression-like behavior. Psychoneuroendocrinology 136:105620. https:\/\/doi.org\/10.1016\/j.psyneuen.2021.105620","journal-title":"Psychoneuroendocrinology"},{"key":"6192_CR202","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2013.83","volume":"3","author":"KJ Davey","year":"2013","unstructured":"Davey KJ, Cotter PD, O\u2019Sullivan O, Crispie F, Dinan TG, Cryan JF et al (2013) Antipsychotics and the gut microbiome: olanzapine-induced metabolic dysfunction is attenuated by antibiotic administration in the rat. Transl Psychiatry 3:e309. https:\/\/doi.org\/10.1038\/tp.2013.83","journal-title":"Transl Psychiatry"},{"key":"6192_CR203","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1097\/CM9.0000000000000245","volume":"132","author":"S Zhang","year":"2019","unstructured":"Zhang S, Chen DC (2019) Facing a new challenge: the adverse effects of antibiotics on gut microbiota and host immunity. Chin Med J (Engl) 132:1135\u20131138. https:\/\/doi.org\/10.1097\/CM9.0000000000000245","journal-title":"Chin Med J (Engl)"},{"key":"6192_CR204","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nature13828","volume":"517","author":"CG Buffie","year":"2015","unstructured":"Buffie CG, Bucci V, Stein RR, McKenney PT, Ling L, Gobourne A et al (2015) Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 517:205\u2013208. https:\/\/doi.org\/10.1038\/nature13828","journal-title":"Nature"},{"key":"6192_CR205","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.3389\/fmicb.2018.01995","volume":"9","author":"N Bhaskaran","year":"2018","unstructured":"Bhaskaran N, Quigley C, Paw C, Butala S, Schneider E, Pandiyan P (2018) Role of short chain fatty acids in controlling t(regs) and immunopathology during mucosal infection. Front Microbiol 9:1995. https:\/\/doi.org\/10.3389\/fmicb.2018.01995","journal-title":"Front Microbiol"},{"key":"6192_CR206","doi-asserted-by":"publisher","first-page":"6684","DOI":"10.1007\/s12035-022-02990-5","volume":"59","author":"SS Praveenraj","year":"2022","unstructured":"Praveenraj SS, Sonali S, Anand N, Tousif HA, Vichitra C, Kalyan M et al (2022) The role of a gut microbial-derived metabolite, trimethylamine n-oxide (TMAO), in neurological disorders. Mol Neurobiol 59:6684\u20136700. https:\/\/doi.org\/10.1007\/s12035-022-02990-5","journal-title":"Mol Neurobiol"},{"key":"6192_CR207","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-72184-3","volume":"10","author":"L Chen","year":"2020","unstructured":"Chen L, Chen Y, Zhao M, Zheng L, Fan D (2020) Changes in the concentrations of trimethylamine N-oxide (TMAO) and its precursors in patients with amyotrophic lateral sclerosis. Sci Rep 10:15198. https:\/\/doi.org\/10.1038\/s41598-020-72184-3","journal-title":"Sci Rep"},{"key":"6192_CR208","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci13050790","author":"W Quan","year":"2023","unstructured":"Quan W, Qiao CM, Niu GY, Wu J, Zhao LP, Cui C et al (2023) Trimethylamine n-oxide exacerbates neuroinflammation and motor dysfunction in an acute MPTP mice model of Parkinson\u2019s disease. Brain Sci. https:\/\/doi.org\/10.3390\/brainsci13050790","journal-title":"Brain Sci"},{"key":"6192_CR209","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00394-022-03011-w","volume":"62","author":"L Zhang","year":"2023","unstructured":"Zhang L, Yu F, Xia J (2023) Trimethylamine N-oxide: role in cell senescence and age-related diseases. Eur J Nutr 62:525\u2013541. https:\/\/doi.org\/10.1007\/s00394-022-03011-w","journal-title":"Eur J Nutr"},{"key":"6192_CR210","doi-asserted-by":"publisher","first-page":"1826681","DOI":"10.3389\/fphar.2026.1826681","volume":"17","author":"T Xu","year":"2026","unstructured":"Xu T, Roy SP, Hadia R, Annu BS, Panchal A (2026) The gut-brain axis in pharmacology: microbiome-driven modulation of CNS drugs and neuropsychiatric outcomes. Front Pharmacol 17:1826681. https:\/\/doi.org\/10.3389\/fphar.2026.1826681","journal-title":"Front Pharmacol"},{"key":"6192_CR211","doi-asserted-by":"publisher","first-page":"10028","DOI":"10.3390\/ijms221810028","volume":"22","author":"J Doroszkiewicz","year":"2021","unstructured":"Doroszkiewicz J, Groblewska M, Mroczko B (2021) The role of gut microbiota and gut-brain interplay in selected diseases of the central nervous system. Int J Mol Sci 22:10028. https:\/\/doi.org\/10.3390\/ijms221810028","journal-title":"Int J Mol Sci"},{"key":"6192_CR212","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1124\/dmd.115.065698","volume":"43","author":"CD Klaassen","year":"2015","unstructured":"Klaassen CD, Cui JY (2015) Review: mechanisms of how the intestinal microbiota alters the effects of drugs and bile acids. Drug Metab Dispos 43:1505\u20131521. https:\/\/doi.org\/10.1124\/dmd.115.065698","journal-title":"Drug Metab Dispos"},{"key":"6192_CR213","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1124\/dmd.115.063545","volume":"43","author":"FP Selwyn","year":"2015","unstructured":"Selwyn FP, Cui JY, Klaassen CD (2015) RNA-Seq quantification of hepatic drug processing genes in germ-free mice. Drug Metab Dispos 43:1572\u20131580. https:\/\/doi.org\/10.1124\/dmd.115.063545","journal-title":"Drug Metab Dispos"},{"key":"6192_CR214","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/tera.1420440209","volume":"44","author":"S Takeno","year":"1991","unstructured":"Takeno S, Sakai T (1991) Involvement of the intestinal microflora in nitrazepam-induced teratogenicity in rats and its relationship to nitroreduction. Teratology 44:209\u2013214. https:\/\/doi.org\/10.1002\/tera.1420440209","journal-title":"Teratology"},{"key":"6192_CR215","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/hep.29327","volume":"67","author":"LY Yip","year":"2018","unstructured":"Yip LY, Aw CC, Lee SH, Hong YS, Ku HC, Xu WH et al (2018) The liver-gut microbiota axis modulates hepatotoxicity of tacrine in the rat. Hepatology 67:282\u2013295. https:\/\/doi.org\/10.1002\/hep.29327","journal-title":"Hepatology"},{"key":"6192_CR216","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1212\/01.wnl.0000221672.01272.ba","volume":"66","author":"M Pierantozzi","year":"2006","unstructured":"Pierantozzi M, Pietroiusti A, Brusa L, Galati S, Stefani A, Lunardi G et al (2006) Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations. Neurology 66:1824\u20131829. https:\/\/doi.org\/10.1212\/01.wnl.0000221672.01272.ba","journal-title":"Neurology"},{"key":"6192_CR217","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1211\/jpp\/61.10.0005","volume":"61","author":"M Niehues","year":"2009","unstructured":"Niehues M, Hensel A (2009) In-vitro interaction of L-dopa with bacterial adhesins of Helicobacter pylori: an explanation for clinicial differences in bioavailability? J Pharm Pharmacol 61:1303\u20131307. https:\/\/doi.org\/10.1211\/jpp\/61.10.0005","journal-title":"J Pharm Pharmacol"},{"key":"6192_CR218","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jad.2016.09.012","volume":"208","author":"D Macedo","year":"2017","unstructured":"Macedo D, Filho A, Soares de Sousa CN, Quevedo J, Barichello T, Junior HVN et al (2017) Antidepressants, antimicrobials or both? Gut microbiota dysbiosis in depression and possible implications of the antimicrobial effects of antidepressant drugs for antidepressant effectiveness. J Affect Disord 208:22\u201332. https:\/\/doi.org\/10.1016\/j.jad.2016.09.012","journal-title":"J Affect Disord"},{"key":"6192_CR219","doi-asserted-by":"publisher","first-page":"7551","DOI":"10.3390\/ijms21207551","volume":"21","author":"K Suganya","year":"2020","unstructured":"Suganya K, Koo B-S (2020) Gut\u2013brain axis: role of gut microbiota on neurological disorders and how probiotics\/prebiotics beneficially modulate microbial and immune pathways to improve brain functions. Int J Mol Sci 21:7551. https:\/\/doi.org\/10.3390\/ijms21207551","journal-title":"Int J Mol Sci"},{"key":"6192_CR220","doi-asserted-by":"publisher","first-page":"2102878","DOI":"10.1080\/19490976.2022.2102878","volume":"14","author":"H Ahmed","year":"2022","unstructured":"Ahmed H, Leyrolle Q, Koistinen V, K\u00e4rkk\u00e4inen O, Lay\u00e9 S, Delzenne N et al (2022) Microbiota-derived metabolites as drivers of gut\u2013brain communication. Gut microbes 14:2102878. https:\/\/doi.org\/10.1080\/19490976.2022.2102878","journal-title":"Gut microbes"},{"key":"6192_CR221","doi-asserted-by":"publisher","first-page":"6643","DOI":"10.3390\/ijms23126643","volume":"23","author":"JE Lee","year":"2022","unstructured":"Lee JE, Walton D, O\u2019Connor CP, Wammes M, Burton JP, Osuch EA (2022) Drugs, guts, brains, but not rock and roll: the need to consider the role of gut microbiota in contemporary mental health and wellness of emerging adults. Int J Mol Sci 23:6643. https:\/\/doi.org\/10.3390\/ijms23126643","journal-title":"Int J Mol Sci"},{"key":"6192_CR222","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.1111\/bph.14366","volume":"175","author":"J Walsh","year":"2018","unstructured":"Walsh J, Griffin BT, Clarke G, Hyland NP (2018) Drug-gut microbiota interactions: implications for neuropharmacology. Br J Pharmacol 175:4415\u201329. https:\/\/doi.org\/10.1111\/bph.14366","journal-title":"Br J Pharmacol"},{"key":"6192_CR223","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/med.22077","volume":"45","author":"J Wang","year":"2025","unstructured":"Wang J, Zhou T (2025) Unveiling gut microbiota\u2019s role: bidirectional regulation of drug transport for improved safety. Med Res Rev 45:311\u2013343. https:\/\/doi.org\/10.1002\/med.22077","journal-title":"Med Res Rev"},{"key":"6192_CR224","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.phrs.2012.07.009","volume":"69","author":"HJ Haiser","year":"2013","unstructured":"Haiser HJ, Turnbaugh PJ (2013) Developing a metagenomic view of xenobiotic metabolism. Pharmacol Res 69:21\u201331. https:\/\/doi.org\/10.1016\/j.phrs.2012.07.009","journal-title":"Pharmacol Res"},{"key":"6192_CR225","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s00213-019-5185-8","volume":"236","author":"S Cussotto","year":"2019","unstructured":"Cussotto S, Clarke G, Dinan TG, Cryan JF (2019) Psychotropics and the microbiome: a chamber of secrets. Psychopharmacology 236:1411\u20131432. https:\/\/doi.org\/10.1007\/s00213-019-5185-8","journal-title":"Psychopharmacology"},{"key":"6192_CR226","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.574529","volume":"12","author":"N Palacios","year":"2021","unstructured":"Palacios N, Hannoun A, Flahive J, Ward D, Goostrey K, Deb A et al (2021) Effect of levodopa initiation on the gut microbiota in Parkinson\u2019s disease. Front Neurol 12:574529. https:\/\/doi.org\/10.3389\/fneur.2021.574529","journal-title":"Front Neurol"},{"key":"6192_CR227","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1111\/ene.14644","volume":"28","author":"M Melis","year":"2021","unstructured":"Melis M, Vascellari S, Santoru ML, Oppo V, Fabbri M, Sarchioto M et al (2021) Gut microbiota and metabolome distinctive features in Parkinson disease: focus on levodopa and levodopa-carbidopa intrajejunal gel. Eur J Neurol 28:1198\u20131209. https:\/\/doi.org\/10.1111\/ene.14644","journal-title":"Eur J Neurol"},{"key":"6192_CR228","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/mds.26942","volume":"32","author":"EM Hill-Burns","year":"2017","unstructured":"Hill-Burns EM, Debelius JW, Morton JT, Wissemann WT, Lewis MR, Wallen ZD et al (2017) Parkinson\u2019s disease and Parkinson\u2019s disease medications have distinct signatures of the gut microbiome. Mov Disord 32:739\u2013749. https:\/\/doi.org\/10.1002\/mds.26942","journal-title":"Mov Disord"},{"key":"6192_CR229","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27196591","volume":"27","author":"JK Jo","year":"2022","unstructured":"Jo JK, Lee G, Nguyen CD, Park SE, Kim EJ, Kim HW et al (2022) Effects of donepezil treatment on brain metabolites, gut microbiota, and gut metabolites in an amyloid beta-induced cognitive impairment mouse pilot model. Molecules 27:6591. https:\/\/doi.org\/10.3390\/molecules27196591","journal-title":"Molecules"},{"key":"6192_CR230","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232315230","volume":"23","author":"CL Dai","year":"2022","unstructured":"Dai CL, Liu F, Iqbal K, Gong CX (2022) Gut microbiota and immunotherapy for Alzheimer\u2019s disease. Int J Mol Sci 23:15230. https:\/\/doi.org\/10.3390\/ijms232315230","journal-title":"Int J Mol Sci"},{"key":"6192_CR231","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41398-019-0466-x","volume":"9","author":"I Lukic","year":"2019","unstructured":"Lukic I, Getselter D, Ziv O, Oron O, Reuveni E, Koren O et al (2019) Antidepressants affect gut microbiota and Ruminococcus flavefaciens is able to abolish their effects on depressive-like behavior. Transl Psychiatry 9:133. https:\/\/doi.org\/10.1038\/s41398-019-0466-x","journal-title":"Transl Psychiatry"},{"key":"6192_CR232","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.6199","volume":"7","author":"M Lyte","year":"2019","unstructured":"Lyte M, Daniels KM, Schmitz-Esser S (2019) Fluoxetine-induced alteration of murine gut microbial community structure: evidence for a microbial endocrinology-based mechanism of action responsible for fluoxetine-induced side effects. PeerJ 7:e6199. https:\/\/doi.org\/10.7717\/peerj.6199","journal-title":"PeerJ"},{"key":"6192_CR233","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3390\/jcm8020164","volume":"8","author":"P Liskiewicz","year":"2019","unstructured":"Liskiewicz P, Pelka-Wysiecka J, Kaczmarczyk M, Loniewski I, Wronski M, Baba-Kubis A et al (2019) Fecal microbiota analysis in patients going through a depressive episode during treatment in a psychiatric hospital setting. J Clin Med 8:164. https:\/\/doi.org\/10.3390\/jcm8020164","journal-title":"J Clin Med"},{"key":"6192_CR234","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41467-019-14177-z","volume":"11","author":"A Vich Vila","year":"2020","unstructured":"Vich Vila A, Collij V, Sanna S, Sinha T, Imhann F, Bourgonje AR et al (2020) Impact of commonly used drugs on the composition and metabolic function of the gut microbiota. Nat Commun 11:362. https:\/\/doi.org\/10.1038\/s41467-019-14177-z","journal-title":"Nat Commun"},{"key":"6192_CR235","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/phar.1890","volume":"37","author":"SA Flowers","year":"2017","unstructured":"Flowers SA, Evans SJ, Ward KM, McInnis MG, Ellingrod VL (2017) Interaction between atypical antipsychotics and the gut microbiome in a bipolar disease cohort. Pharmacotherapy 37:261\u2013267. https:\/\/doi.org\/10.1002\/phar.1890","journal-title":"Pharmacotherapy"},{"key":"6192_CR236","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00213-011-2555-2","volume":"221","author":"KJ Davey","year":"2012","unstructured":"Davey KJ, O\u2019Mahony SM, Schellekens H, O\u2019Sullivan O, Bienenstock J, Cotter PD et al (2012) Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters. Psychopharmacology 221:155\u2013169. https:\/\/doi.org\/10.1007\/s00213-011-2555-2","journal-title":"Psychopharmacology"},{"key":"6192_CR237","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115225","volume":"9","author":"AP Morgan","year":"2014","unstructured":"Morgan AP, Crowley JJ, Nonneman RJ, Quackenbush CR, Miller CN, Ryan AK et al (2014) The antipsychotic olanzapine interacts with the gut microbiome to cause weight gain in mouse. PLoS ONE 9:e115225. https:\/\/doi.org\/10.1371\/journal.pone.0115225","journal-title":"PLoS ONE"},{"key":"6192_CR238","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.897926","volume":"13","author":"Z Zhu","year":"2022","unstructured":"Zhu Z, Gu Y, Zeng C, Yang M, Yu H, Chen H et al (2022) Olanzapine-induced lipid disturbances: a potential mechanism through the gut microbiota-brain axis. Front Pharmacol 13:897926. https:\/\/doi.org\/10.3389\/fphar.2022.897926","journal-title":"Front Pharmacol"},{"key":"6192_CR239","doi-asserted-by":"publisher","first-page":"4531","DOI":"10.1111\/bph.16507","volume":"181","author":"S Kamath","year":"2024","unstructured":"Kamath S, Hunter A, Collins K, Wignall A, Joyce P (2024) The atypical antipsychotics lurasidone and olanzapine exert contrasting effects on the gut microbiome and metabolic function of rats. Br J Pharmacol 181:4531\u20134545. https:\/\/doi.org\/10.1111\/bph.16507","journal-title":"Br J Pharmacol"},{"key":"6192_CR240","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2015.135","volume":"5","author":"SM Bahr","year":"2015","unstructured":"Bahr SM, Tyler BC, Wooldridge N, Butcher BD, Burns TL, Teesch LM et al (2015) Use of the second-generation antipsychotic, risperidone, and secondary weight gain are associated with an altered gut microbiota in children. Transl Psychiatry 5:e652. https:\/\/doi.org\/10.1038\/tp.2015.135","journal-title":"Transl Psychiatry"},{"key":"6192_CR241","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.schres.2018.05.017","volume":"201","author":"X Yuan","year":"2018","unstructured":"Yuan X, Zhang P, Wang Y, Liu Y, Li X, Kumar BU et al (2018) Changes in metabolism and microbiota after 24-week risperidone treatment in drug naive, normal weight patients with first episode schizophrenia. Schizophr Res 201:299\u2013306. https:\/\/doi.org\/10.1016\/j.schres.2018.05.017","journal-title":"Schizophr Res"},{"key":"6192_CR242","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1016\/j.ebiom.2015.10.018","volume":"2","author":"SM Bahr","year":"2015","unstructured":"Bahr SM, Weidemann BJ, Castro AN, Walsh JW, deLeon O, Burnett CM et al (2015) Risperidone-induced weight gain is mediated through shifts in the gut microbiome and suppression of energy expenditure. EBioMedicine 2:1725\u20131734. https:\/\/doi.org\/10.1016\/j.ebiom.2015.10.018","journal-title":"EBioMedicine"},{"key":"6192_CR243","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1007\/s00213-018-5006-5","volume":"236","author":"S Cussotto","year":"2019","unstructured":"Cussotto S, Strain CR, Fouhy F, Strain RG, Peterson VL, Clarke G et al (2019) Differential effects of psychotropic drugs on microbiome composition and gastrointestinal function. Psychopharmacology 236:1671\u20131685. https:\/\/doi.org\/10.1007\/s00213-018-5006-5","journal-title":"Psychopharmacology"},{"key":"6192_CR244","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1242856","volume":"14","author":"K Thai","year":"2023","unstructured":"Thai K, Taylor MW, Fernandes T, Akinade EA, Campbell SL (2023) Topiramate alters the gut microbiome to aid in its anti-seizure effect. Front Microbiol 14:1242856. https:\/\/doi.org\/10.3389\/fmicb.2023.1242856","journal-title":"Front Microbiol"},{"key":"6192_CR245","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12866-018-1373-7","volume":"18","author":"B Getachew","year":"2018","unstructured":"Getachew B, Aubee JI, Schottenfeld RS, Csoka AB, Thompson KM, Tizabi Y (2018) Ketamine interactions with gut-microbiota in rats: relevance to its antidepressant and anti-inflammatory properties. BMC Microbiol 18:222. https:\/\/doi.org\/10.1186\/s12866-018-1373-7","journal-title":"BMC Microbiol"},{"key":"6192_CR246","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.17061","volume":"12","author":"X Zou","year":"2024","unstructured":"Zou X, Zou G, Zou X, Wang K, Chen Z (2024) Gut microbiota and its metabolites in Alzheimer\u2019s disease: from pathogenesis to treatment. PeerJ 12:e17061. https:\/\/doi.org\/10.7717\/peerj.17061","journal-title":"PeerJ"},{"key":"6192_CR247","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fcimb.2020.00047","volume":"10","author":"L Peng","year":"2020","unstructured":"Peng L, Li L, He XL, Yu JY, Zeng ZJ, Yang WJ et al (2020) Memantine displays antimicrobial activity by enhancing Escherichia coli pathogen-induced formation of neutrophil extracellular traps. Front Cell Infect Microbiol 10:47. https:\/\/doi.org\/10.3389\/fcimb.2020.00047","journal-title":"Front Cell Infect Microbiol"},{"key":"6192_CR248","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1089\/mdr.2020.0511","volume":"28","author":"Y Xiao","year":"2022","unstructured":"Xiao Y, Zhang TS, Li YH, Liu CF, Yang SJ, Zeng LT et al (2022) Memantine promotes bactericidal effect of neutrophils against infection with Pseudomonas aeruginosa and its drug-resistant strain, by improving reactive oxygen species generation. Microb Drug Resist 28:7\u201317. https:\/\/doi.org\/10.1089\/mdr.2020.0511","journal-title":"Microb Drug Resist"},{"key":"6192_CR249","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.112593","volume":"28","author":"D Hisamatsu","year":"2025","unstructured":"Hisamatsu D, Masuoka H, Takeshige-Amano H, Kurokawa R, Ogata Y, Suda W et al (2025) Acetylcholinesterase inhibitors considerably affect the salivary microbiome in patients with Alzheimer\u2019s disease. iScience 28:112593. https:\/\/doi.org\/10.1016\/j.isci.2025.112593","journal-title":"iScience"},{"key":"6192_CR250","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10091527","volume":"10","author":"Z Valiukas","year":"2022","unstructured":"Valiukas Z, Ephraim R, Tangalakis K, Davidson M, Apostolopoulos V, Feehan J (2022) Immunotherapies for Alzheimer\u2019s disease-a review. Vaccines 10:1527. https:\/\/doi.org\/10.3390\/vaccines10091527","journal-title":"Vaccines"},{"key":"6192_CR251","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/mds.27581","volume":"34","author":"M Barichella","year":"2019","unstructured":"Barichella M, Severgnini M, Cilia R, Cassani E, Bolliri C, Caronni S et al (2019) Unraveling gut microbiota in Parkinson\u2019s disease and atypical parkinsonism. Mov Disord 34:396\u2013405. https:\/\/doi.org\/10.1002\/mds.27581","journal-title":"Mov Disord"},{"key":"6192_CR252","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.08.019","volume":"32","author":"MM Unger","year":"2016","unstructured":"Unger MM, Spiegel J, Dillmann KU, Grundmann D, Philippeit H, Burmann J et al (2016) Short chain fatty acids and gut microbiota differ between patients with Parkinson\u2019s disease and age-matched controls. Parkinsonism Relat Disord 32:66\u201372. https:\/\/doi.org\/10.1016\/j.parkreldis.2016.08.019","journal-title":"Parkinsonism Relat Disord"},{"key":"6192_CR253","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.parkreldis.2019.11.020","volume":"70","author":"D Grun","year":"2020","unstructured":"Grun D, Zimmer VC, Kauffmann J, Spiegel J, Dillmann U, Schwiertz A et al (2020) Impact of oral COMT-inhibitors on gut microbiota and short chain fatty acids in Parkinson\u2019s disease. Parkinsonism Relat Disord 70:20\u201322. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.11.020","journal-title":"Parkinsonism Relat Disord"},{"key":"6192_CR254","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1038\/s41564-024-01853-0","volume":"9","author":"FC Pereira","year":"2024","unstructured":"Pereira FC, Ge X, Kristensen JM, Kirkegaard RH, Maritsch K, Szamosvari D et al (2024) The Parkinson\u2019s disease drug entacapone disrupts gut microbiome homoeostasis via iron sequestration. Nat Microbiol 9:3165\u20133183. https:\/\/doi.org\/10.1038\/s41564-024-01853-0","journal-title":"Nat Microbiol"},{"key":"6192_CR255","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.01191-21","volume":"7","author":"SP van Kessel","year":"2022","unstructured":"van Kessel SP, Bullock A, van Dijk G, El Aidy S (2022) Parkinson\u2019s disease medication alters small intestinal motility and microbiota composition in healthy rats. mSystems 7:e01191-21. https:\/\/doi.org\/10.1128\/msystems.01191-21","journal-title":"mSystems"},{"key":"6192_CR256","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41531-020-0112-6","volume":"6","author":"ZD Wallen","year":"2020","unstructured":"Wallen ZD, Appah M, Dean MN, Sesler CL, Factor SA, Molho E et al (2020) Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens. NPJ Parkinsons Dis 6:11. https:\/\/doi.org\/10.1038\/s41531-020-0112-6","journal-title":"NPJ Parkinsons Dis"},{"key":"6192_CR257","doi-asserted-by":"publisher","first-page":"11245","DOI":"10.3390\/ijms231911245","volume":"23","author":"A Goralczyk-Binkowska","year":"2022","unstructured":"Goralczyk-Binkowska A, Szmajda-Krygier D, Kozlowska E (2022) The microbiota-gut-brain axis in psychiatric disorders. Int J Mol Sci 23:11245. https:\/\/doi.org\/10.3390\/ijms231911245","journal-title":"Int J Mol Sci"},{"key":"6192_CR258","doi-asserted-by":"publisher","first-page":"10813","DOI":"10.1007\/s12035-025-04846-0","volume":"62","author":"YN Ramadan","year":"2025","unstructured":"Ramadan YN, Alqifari SF, Alshehri K, Alhowiti A, Mirghani H, Alrasheed T et al (2025) Microbiome gut-brain-axis: impact on brain development and mental health. Mol Neurobiol 62:10813\u201310833. https:\/\/doi.org\/10.1007\/s12035-025-04846-0","journal-title":"Mol Neurobiol"},{"key":"6192_CR259","doi-asserted-by":"publisher","unstructured":"Tang E-K, Loo K-Y, Thye AY-K, Law JW-F, Tan LT-H, Selvaraja M et al (2024) The impact of antidepressants on gut microbiome and depression management. Prog Microbes Mol Biol 7:a0000446. https:\/\/doi.org\/10.36877\/pmmb.a0000446","DOI":"10.36877\/pmmb.a0000446"},{"key":"6192_CR260","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41398-021-01254-5","volume":"11","author":"W Zhang","year":"2021","unstructured":"Zhang W, Qu W, Wang H, Yan H (2021) Antidepressants fluoxetine and amitriptyline induce alterations in intestinal microbiota and gut microbiome function in rats exposed to chronic unpredictable mild stress. Transl Psychiatry 11:131. https:\/\/doi.org\/10.1038\/s41398-021-01254-5","journal-title":"Transl Psychiatry"},{"key":"6192_CR261","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.7150\/ijms.37322","volume":"16","author":"L Sun","year":"2019","unstructured":"Sun L, Zhang H, Cao Y, Wang C, Zhao C, Wang H et al (2019) Fluoxetine ameliorates dysbiosis in a depression model induced by chronic unpredicted mild stress in mice. Int J Med Sci 16:1260\u20131270. https:\/\/doi.org\/10.7150\/ijms.37322","journal-title":"Int J Med Sci"},{"key":"6192_CR262","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117748","volume":"182","author":"YB Lee","year":"2025","unstructured":"Lee YB, Cho YJ, Kim JK (2025) The unique role of fluoxetine in alleviating depression and anxiety by regulating gut microbiota and the expression of vagus nerve-mediated serotonin and melanocortin-4 receptors. Biomed Pharmacother 182:117748. https:\/\/doi.org\/10.1016\/j.biopha.2024.117748","journal-title":"Biomed Pharmacother"},{"key":"6192_CR263","doi-asserted-by":"publisher","first-page":"1347867","DOI":"10.3389\/fpsyt.2024.1347867","volume":"15","author":"C Du","year":"2024","unstructured":"Du C, Zhang T, Feng C, Sun Q, Chen Z, Shen X et al (2024) The effects of venlafaxine on depressive-like behaviors and gut microbiome in cuprizone-treated mice. Front Psychiatry 15:1347867. https:\/\/doi.org\/10.3389\/fpsyt.2024.1347867","journal-title":"Front Psychiatry"},{"key":"6192_CR264","doi-asserted-by":"publisher","first-page":"16050","DOI":"10.1073\/pnas.1102999108","volume":"108","author":"JA Bravo","year":"2011","unstructured":"Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG et al (2011) Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A 108:16050\u201316055. https:\/\/doi.org\/10.1073\/pnas.1102999108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6192_CR265","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jad.2017.11.063","volume":"228","author":"QX Ng","year":"2018","unstructured":"Ng QX, Peters C, Ho CYX, Lim DY, Yeo WS (2018) A meta-analysis of the use of probiotics to alleviate depressive symptoms. J Affect Disord 228:13\u201319. https:\/\/doi.org\/10.1016\/j.jad.2017.11.063","journal-title":"J Affect Disord"},{"key":"6192_CR266","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105664","volume":"167","author":"ZE Ilhan","year":"2022","unstructured":"Ilhan ZE, Brochard V, Lapaque N, Auvin S, Lepage P (2022) Exposure to anti-seizure medications impact growth of gut bacterial species and subsequent host response. Neurobiol Dis 167:105664. https:\/\/doi.org\/10.1016\/j.nbd.2022.105664","journal-title":"Neurobiol Dis"},{"key":"6192_CR267","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2024.149367","volume":"1849","author":"R Yuwattana","year":"2025","unstructured":"Yuwattana R, Suparan K, Kerdphoo S, Arunsak B, Sanguansermsri C, Katanyuwong K et al (2025) Altered gut microbiome profiles in epileptic children are associated with spectrum of anti-seizure medication responsiveness. Brain Res 1849:149367. https:\/\/doi.org\/10.1016\/j.brainres.2024.149367","journal-title":"Brain Res"},{"key":"6192_CR268","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2021.105340","volume":"162","author":"X Gong","year":"2022","unstructured":"Gong X, Liu Y, Liu X, Li AQ, Guo KD, Zhou D et al (2022) Analysis of gut microbiota in patients with epilepsy treated with valproate: results from a three months observational prospective cohort study. Microb Pathog 162:105340. https:\/\/doi.org\/10.1016\/j.micpath.2021.105340","journal-title":"Microb Pathog"},{"key":"6192_CR269","doi-asserted-by":"publisher","DOI":"10.1186\/s12868-022-00690-3","volume":"23","author":"X Li","year":"2022","unstructured":"Li X, Wang Q, Wu D, Zhang DW, Li SC, Zhang SW et al (2022) The effect of a novel anticonvulsant chemical Q808 on gut microbiota and hippocampus neurotransmitters in pentylenetetrazole-induced seizures in rats. BMC Neurosci 23:7. https:\/\/doi.org\/10.1186\/s12868-022-00690-3","journal-title":"BMC Neurosci"},{"key":"6192_CR270","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41531-022-00327-6","volume":"8","author":"H Sun","year":"2022","unstructured":"Sun H, Zhao F, Liu Y, Ma T, Jin H, Quan K et al (2022) Probiotics synergized with conventional regimen in managing Parkinson\u2019s disease. NPJ Parkinsons Dis 8:62. https:\/\/doi.org\/10.1038\/s41531-022-00327-6","journal-title":"NPJ Parkinsons Dis"},{"key":"6192_CR271","doi-asserted-by":"publisher","DOI":"10.1002\/fsn3.4698","volume":"13","author":"V Elahinejad","year":"2025","unstructured":"Elahinejad V, Khorasanian AS, Tehrani-Doost M, Khosravi-Darani K, Mirsepasi Z, Effatpanah M et al (2025) Effects of probiotics as adjunctive therapy to fluoxetine on depression severity and serum brain-derived neurotrophic factor, cortisol, and adrenocorticotropic hormone in patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial. Food Sci Nutr 13:e4698. https:\/\/doi.org\/10.1002\/fsn3.4698","journal-title":"Food Sci Nutr"},{"key":"6192_CR272","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1001\/jamapsychiatry.2023.1817","volume":"80","author":"VL Nikolova","year":"2023","unstructured":"Nikolova VL, Cleare AJ, Young AH, Stone JM (2023) Acceptability, tolerability, and estimates of putative treatment effects of probiotics as adjunctive treatment in patients with depression: a randomized clinical trial. JAMA Psychiat 80:842\u2013847. https:\/\/doi.org\/10.1001\/jamapsychiatry.2023.1817","journal-title":"JAMA Psychiat"},{"key":"6192_CR273","doi-asserted-by":"publisher","DOI":"10.5812\/archneurosci.60507","volume":"5","author":"Z Ghorbani","year":"2018","unstructured":"Ghorbani Z, Nazari S, Etesam F, Nourimajd S, Ahmadpanah M, Razeghi Jahromi S (2018) The effect of synbiotic as an adjuvant therapy to fluoxetine in moderate depression: a randomized multicenter trial. Arch Neurosci 5:e60507. https:\/\/doi.org\/10.5812\/archneurosci.60507","journal-title":"Arch Neurosci"},{"key":"6192_CR274","doi-asserted-by":"publisher","DOI":"10.15275\/rusomj.2021.0109","volume":"10","author":"SR Arifdjanova","year":"2021","unstructured":"Arifdjanova SR, Abrurakhmanova ZZ, Bizulya ES, Gumenyuk LN, Sorokina LE, Gerbali OY (2021) The role of probiotics in combination therapy of depressive disorders. Russ Open Med J 10:e0109. https:\/\/doi.org\/10.15275\/rusomj.2021.0109","journal-title":"Russ Open Med J"},{"key":"6192_CR275","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s41398-022-01977-z","volume":"12","author":"AC Schaub","year":"2022","unstructured":"Schaub AC, Schneider E, Vazquez-Castellanos JF, Schweinfurth N, Kettelhack C, Doll JPK et al (2022) Clinical, gut microbial and neural effects of a probiotic add-on therapy in depressed patients: a randomized controlled trial. Transl Psychiatry 12:227. https:\/\/doi.org\/10.1038\/s41398-022-01977-z","journal-title":"Transl Psychiatry"},{"key":"6192_CR276","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/WNF.0000000000000299","volume":"41","author":"T Miyaoka","year":"2018","unstructured":"Miyaoka T, Kanayama M, Wake R, Hashioka S, Hayashida M, Nagahama M et al (2018) Clostridium butyricum MIYAIRI 588 as adjunctive therapy for treatment-resistant major depressive disorder: a prospective open-label trial. Clin Neuropharmacol 41:151\u2013155. https:\/\/doi.org\/10.1097\/WNF.0000000000000299","journal-title":"Clin Neuropharmacol"},{"issue":"Suppl 1","key":"6192_CR277","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1016\/j.jfma.2018.09.004","volume":"118","author":"PH Kuo","year":"2019","unstructured":"Kuo PH, Chung YE (2019) Moody microbiome: challenges and chances. J Formos Med Assoc 118(Suppl 1):S42\u2013S54. https:\/\/doi.org\/10.1016\/j.jfma.2018.09.004","journal-title":"J Formos Med Assoc"},{"key":"6192_CR278","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13099-024-00664-2","volume":"16","author":"S Mushraf","year":"2024","unstructured":"Mushraf S, Chawla K, Fayaz SMA, Mathew AJ, Reddy GPK, Kappettu Gadahad MR et al (2024) Exploring the effects of probiotics on olanzapine-induced metabolic syndrome through the gut microbiota. Gut Pathog 16:77. https:\/\/doi.org\/10.1186\/s13099-024-00664-2","journal-title":"Gut Pathog"},{"key":"6192_CR279","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24087326","author":"Y Ait Chait","year":"2023","unstructured":"Ait Chait Y, Mottawea W, Tompkins TA, Hammami R (2023) Evidence of the dysbiotic effect of psychotropics on gut microbiota and capacity of probiotics to alleviate related dysbiosis in a model of the human colon. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24087326","journal-title":"Int J Mol Sci"},{"key":"6192_CR280","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.71422","volume":"8","author":"M Jafari","year":"2025","unstructured":"Jafari M, Alipour M, Zamani S, Mohtasham Amiri A, Pourabbas P, Hasannejad-Bibalan M (2025) Probiotics as a complementary medicine in neurologic disorders. Health Sci Rep 8:e71422. https:\/\/doi.org\/10.1002\/hsr2.71422","journal-title":"Health Sci Rep"},{"key":"6192_CR281","doi-asserted-by":"publisher","DOI":"10.1111\/1541-4337.70320","volume":"25","author":"H Kim","year":"2026","unstructured":"Kim H, Haque MA, Razzak MA, Jang MJ, Song S, Ku S (2026) Probiotic development strategy centered on stability and regulatory considerations. Compr Rev Food Sci Food Saf 25:e70320. https:\/\/doi.org\/10.1111\/1541-4337.70320","journal-title":"Compr Rev Food Sci Food Saf"},{"key":"6192_CR282","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.3390\/microorganisms13051047","volume":"13","author":"A Goldis","year":"2025","unstructured":"Goldis A, Dragomir R, Mercioni MA, Goldis C, Sirca D, Enatescu I et al (2025) Personalized microbiome modulation to improve clinical outcomes in pediatric inflammatory bowel disease: a multi-omics and interventional approach. Microorganisms 13:1047. https:\/\/doi.org\/10.3390\/microorganisms13051047","journal-title":"Microorganisms"},{"key":"6192_CR283","doi-asserted-by":"publisher","DOI":"10.1016\/j.microb.2025.100497","volume":"8","author":"MA Manan","year":"2025","unstructured":"Manan MA (2025) The role of probiotics in personalized therapeutics: advances in gut microbe-driven interventions. Microbe 8:100497. https:\/\/doi.org\/10.1016\/j.microb.2025.100497","journal-title":"Microbe"},{"key":"6192_CR284","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.880544","volume":"10","author":"S Dash","year":"2022","unstructured":"Dash S, Syed YA, Khan MR (2022) Understanding the role of the gut microbiome in brain development and its association with neurodevelopmental psychiatric disorders. Front Cell Dev Biol 10:880544. https:\/\/doi.org\/10.3389\/fcell.2022.880544","journal-title":"Front Cell Dev Biol"},{"key":"6192_CR285","doi-asserted-by":"publisher","DOI":"10.3390\/nu16162646","volume":"16","author":"SM van Zonneveld","year":"2024","unstructured":"van Zonneveld SM, van den Oever EJ, Haarman BCM, Grandjean EL, Nuninga JO, van de Rest O et al (2024) An anti-inflammatory diet and its potential benefit for individuals with mental disorders and neurodegenerative diseases-a narrative review. Nutrients 16:2646. https:\/\/doi.org\/10.3390\/nu16162646","journal-title":"Nutrients"},{"key":"6192_CR286","doi-asserted-by":"publisher","first-page":"2297860","DOI":"10.1080\/19490976.2023.2297860","volume":"16","author":"A Chetty","year":"2024","unstructured":"Chetty A, Blekhman R (2024) Multi-omic approaches for host-microbiome data integration. Gut Microbes 16:2297860. https:\/\/doi.org\/10.1080\/19490976.2023.2297860","journal-title":"Gut Microbes"},{"key":"6192_CR287","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12041650","volume":"12","author":"P Tiwari","year":"2023","unstructured":"Tiwari P, Dwivedi R, Bansal M, Tripathi M, Dada R (2023) Role of gut microbiota in neurological disorders and its therapeutic significance. J Clin Med 12:1650. https:\/\/doi.org\/10.3390\/jcm12041650","journal-title":"J Clin Med"},{"key":"6192_CR288","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.667066","volume":"12","author":"JE Martinez","year":"2021","unstructured":"Martinez JE, Kahana DD, Ghuman S, Wilson HP, Wilson J, Kim SCJ et al (2021) Unhealthy lifestyle and gut dysbiosis: a better understanding of the effects of poor diet and nicotine on the intestinal microbiome. Front Endocrinol (Lausanne) 12:667066. https:\/\/doi.org\/10.3389\/fendo.2021.667066","journal-title":"Front Endocrinol (Lausanne)"},{"key":"6192_CR289","doi-asserted-by":"publisher","DOI":"10.3390\/foods14091559","volume":"14","author":"AN Mafe","year":"2025","unstructured":"Mafe AN, Busselberg D (2025) Could a Mediterranean diet modulate Alzheimer\u2019s disease progression? The role of gut microbiota and metabolite signatures in neurodegeneration. Foods 14:1559. https:\/\/doi.org\/10.3390\/foods14091559","journal-title":"Foods"},{"key":"6192_CR290","doi-asserted-by":"publisher","first-page":"6715","DOI":"10.3748\/wjg.v27.i39.6715","volume":"27","author":"S Baldi","year":"2021","unstructured":"Baldi S, Mundula T, Nannini G, Amedei A (2021) Microbiota shaping - the effects of probiotics, prebiotics, and fecal microbiota transplant on cognitive functions: a systematic review. World J Gastroenterol 27:6715\u20136732. https:\/\/doi.org\/10.3748\/wjg.v27.i39.6715","journal-title":"World J Gastroenterol"},{"key":"6192_CR291","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00338-20","volume":"35","author":"SG Sorboni","year":"2022","unstructured":"Sorboni SG, Moghaddam HS, Jafarzadeh-Esfehani R, Soleimanpour S (2022) A comprehensive review on the role of the gut microbiome in human neurological disorders. Clin Microbiol Rev 35:e0033820. https:\/\/doi.org\/10.1128\/CMR.00338-20","journal-title":"Clin Microbiol Rev"},{"key":"6192_CR292","doi-asserted-by":"publisher","first-page":"4173","DOI":"10.1172\/JCI72335","volume":"124","author":"RN Carmody","year":"2014","unstructured":"Carmody RN, Turnbaugh PJ (2014) Host-microbial interactions in the metabolism of therapeutic and diet-derived xenobiotics. J Clin Invest 124:4173\u20134181. https:\/\/doi.org\/10.1172\/JCI72335","journal-title":"J Clin Invest"},{"key":"6192_CR293","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/03602532.2018.1497647","volume":"50","author":"J Zhang","year":"2018","unstructured":"Zhang J, Zhang J, Wang R (2018) Gut microbiota modulates drug pharmacokinetics. Drug Metab Rev 50:357\u2013368. https:\/\/doi.org\/10.1080\/03602532.2018.1497647","journal-title":"Drug Metab Rev"},{"key":"6192_CR294","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s41392-023-01619-w","volume":"8","author":"Q Zhao","year":"2023","unstructured":"Zhao Q, Chen Y, Huang W, Zhou H, Zhang W (2023) Drug-microbiota interactions: an emerging priority for precision medicine. Signal Transduct Target Ther 8:386. https:\/\/doi.org\/10.1038\/s41392-023-01619-w","journal-title":"Signal Transduct Target Ther"},{"key":"6192_CR295","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/cpt.1870","volume":"108","author":"KG Hawkins","year":"2020","unstructured":"Hawkins KG, Casolaro C, Brown JA, Edwards DA, Wikswo JP (2020) The microbiome and the gut-liver-brain axis for central nervous system clinical pharmacology: challenges in specifying and integrating in vitro and in silico models. Clin Pharmacol Ther 108:929\u2013948. https:\/\/doi.org\/10.1002\/cpt.1870","journal-title":"Clin Pharmacol Ther"},{"key":"6192_CR296","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043074","volume":"24","author":"D Dahiya","year":"2023","unstructured":"Dahiya D, Nigam PS (2023) Antibiotic-therapy-induced gut dysbiosis affecting gut microbiota-brain axis and cognition: restoration by intake of probiotics and synbiotics. Int J Mol Sci 24:3074. https:\/\/doi.org\/10.3390\/ijms24043074","journal-title":"Int J Mol Sci"},{"key":"6192_CR297","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1093\/jac\/dkx426","volume":"73","author":"JW Fjalstad","year":"2018","unstructured":"Fjalstad JW, Esaiassen E, Juvet LK, van den Anker JN, Klingenberg C (2018) Antibiotic therapy in neonates and impact on gut microbiota and antibiotic resistance development: a systematic review. J Antimicrob Chemother 73:569\u201380. https:\/\/doi.org\/10.1093\/jac\/dkx426","journal-title":"J Antimicrob Chemother"},{"key":"6192_CR298","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/cpt.1437","volume":"106","author":"A Sharma","year":"2019","unstructured":"Sharma A, Buschmann MM, Gilbert JA (2019) Pharmacomicrobiomics: the holy grail to variability in drug response? Clin Pharmacol Ther 106:317\u2013328. https:\/\/doi.org\/10.1002\/cpt.1437","journal-title":"Clin Pharmacol Ther"},{"key":"6192_CR299","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/nu14010020","volume":"14","author":"R Naomi","year":"2021","unstructured":"Naomi R, Embong H, Othman F, Ghazi HF, Maruthey N, Bahari H (2021) Probiotics for Alzheimer\u2019s disease: a systematic review. Nutrients 14:20. https:\/\/doi.org\/10.3390\/nu14010020","journal-title":"Nutrients"},{"key":"6192_CR300","doi-asserted-by":"publisher","first-page":"1302093","DOI":"10.3389\/fnut.2024.1302093","volume":"11","author":"U Min","year":"2024","unstructured":"Min U, Jin YJ, Jang YJ, Lim J, Kim BY (2024) Personalized probiotic strategy considering bowel habits: impacts on gut microbiota composition and alleviation of gastrointestinal symptoms via Consti-Biome and Sensi-Biome. Front Nutr 11:1302093. https:\/\/doi.org\/10.3389\/fnut.2024.1302093","journal-title":"Front Nutr"},{"key":"6192_CR301","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanmic.2024.07.011","volume":"6","author":"J Rodriguez","year":"2025","unstructured":"Rodriguez J, Hassani Z, Alves Costa Silva C, Betsou F, Carraturo F, Fasano A et al (2025) State of the art and the future of microbiome-based biomarkers: a multidisciplinary Delphi consensus. Lancet Microbe 6:100948. https:\/\/doi.org\/10.1016\/j.lanmic.2024.07.011","journal-title":"Lancet Microbe"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06192-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-06192-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06192-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:53:07Z","timestamp":1792104787000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-06192-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":301,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["6192"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-06192-1","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"16 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no animal experiments carried out for this article.","order":2,"name":"Ethics","label":"Ethical Statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"970"}}